Continuous positive airway pressure

CPAP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Operations: NOMESCO codes — ^WX722 1 out of 7 registries used, show all original rules.	11076
4. Check minimum number of events None	11076
5. Include endpoints None	11076
6. Filter based on genotype QC (FinnGen only)	9978

Control definitions (FinnGen only)

Control exclude: ILD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	CPAP
CONTROL_EXCLUDE	ILD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^WX722
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Continuous positive airway pressure based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	62273	23857	38134
Only index persons	45606	16596	29010
Unadjusted period prevalence (%)
Whole population	0.92	0.68	1.07
Only index persons	0.93	0.61	1.11
Median age at first event (years)
Whole population	57.66	59.07	56.68
Only index persons	62.08	64.84	60.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9978	3879	6099
Unadjusted period prevalence (%)	2.24	1.38	2.80
Median age at first event (years)	63.19	62.16	63.85

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10006: Matched controls
83331

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB07

ATC

prednisone; oral

3.0

322.4

1696

5236

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

322.2

4212

20189

N06AB10

ATC

escitalopram; oral

3.0

321.6

1687

5199

XG405

NOMESCO Finland

Education on PEF monitoring

12.5

321.5

354

244

C03AA03

ATC

hydrochlorothiazide; oral

4.3

320.6

942

1968

GD1LA

NOMESCO Finland

37.5

320.4

229

A12BA01

ATC

potassium chloride; oral

8.8

318.4

444

437

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.4

318.1

1316

3506

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

6.7

316.7

558

728

I20.90

ICD-10 Finland

Angina pectoris, unspecified

364.6

316.7

340

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.3

314.3

915

1897

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

314.2

2789

11262

A10BJ05

ATC

dulaglutide; parenteral

+∞

313.3

321

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.2

311.6

1460

4203

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.7

311.1

1136

2782

TK800

NOMESCO Finland

Hemodialysis

12.2

310.0

346

244

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.6

307.8

829

1614

J96.1

ICD-10 Finland

Chronic respiratory failure

941.4

307.7

433

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

7.7

307.7

1772

2272

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

6248.6

307.7

707

A10BH05

ATC

linagliptin; oral

1422.3

307.7

625

F32.9

ICD-10 Finland

Depressive episode, unspecified

11.0

307.7

1207

1025

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

43.3

307.7

662

136

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

12.4

307.7

514

362

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.2

307.7

6105

19226

A10AB01

ATC

insulin (human); parenteral

132.9

307.7

249

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

1152

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

10.4

307.7

606

512

N05BA04

ATC

oxazepam; oral

2.7

307.7

2310

8208

C07AB02

ATC

metoprolol; systemic

4.3

307.7

1779

4018

I10

ICD-10 Finland

Essential (primary) hypertension

4.1

307.7

7069

30616

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

307.7

520

T89

ICPC

Diabetes insulin dependent

109.9

307.7

307

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.8

307.7

3281

9506

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

4.6

307.7

1426

2924

CL2S4, ,

SPAT

119.3

307.7

319

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

9.2

307.7

1131

1144

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

91.5

307.7

3389

464

R07.4

ICD-10 Finland

Chest pain, unspecified

3.6

307.7

2866

8378

I48

ICD-10 Finland

Atrial fibrillation and flutter

144.6

307.7

2416

183

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

6.8

307.7

804

1056

A10BH01

ATC

sitagliptin; oral

2242.2

307.7

1233

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1038.9

307.7

361

WX882

NOMESCO Finland

High dependency care

13.5

307.7

831

554

I48.2

ICD-10 Finland

Chronic atrial fibrillation

323.2

307.7

445

I48.1

ICD-10 Finland

Persistent atrial fibrillation

161.8

307.7

410

I42.0

ICD-10 Finland

Dilated cardiomyopathy

37.9

307.7

313

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

67.5

307.7

1722

256

R60.0

ICD-10 Finland

Localized oedema

3.3

307.7

1437

4006

XCK10

NOMESCO Finland

Photography of fundus of eye

4.4

307.7

923

1862

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.8

307.7

2800

6183

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

307.7

435

A10AE05

ATC

insulin detemir; parenteral

1145.9

307.7

522

B01AA03

ATC

warfarin; systemic

14.1

307.7

2054

1495

I20.99

ICD-10 Finland

Angina pectoris, unspecified

87.4

307.7

565

C10AX09

ATC

ezetimibe; oral

3.9

307.7

1505

3662

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

106.3

307.7

1083

T90

ICPC

Diabetes non-insulin dependent

41.1

307.7

3410

1034

E11

ICD-10 Finland

Type 2 diabetes mellitus

48.3

307.7

2243

496

C03DA01

ATC

spironolactone; oral

9.8

307.7

1770

1783

I35.0

ICD-10 Finland

Aortic (valve) stenosis

7.3

307.7

566

682

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1177.6

307.7

405

R4110

NOMESCO Finland

Physiotherapy

3.2

307.7

3651

12723

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

66.2

307.7

492

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

9.7

307.7

740

679

C01BC04

ATC

flecainide; systemic

57.7

307.7

217

201

Kela drug reimbursment

Chronic cardiac insufficiency

30.0

307.7

601

177

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

307.7

537

AA1AD

NOMESCO Finland

CT of head and brain

3.8

307.7

3010

8460

Angiography of the heart and coronary arteries

61.9

307.7

535

T36

ICD-10 Finland

Poisoning by systemic antibiotics

16.0

307.7

345

185

J96.0

ICD-10 Finland

Acute respiratory failure

31.1

307.7

297

A10AE04

ATC

insulin glargine; parenteral

456.2

307.7

1247

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

10.3

307.7

513

433

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

12.0

307.7

964

736

SPAT1254

SPAT

Administration of medicine

3.6

307.7

1402

3641

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.7

307.7

1321

3259

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

88.3

307.7

863

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

1474

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

116.0

307.7

553

I50.0

ICD-10 Finland

Congestive heart failure

52.6

307.7

1237

223

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

51.2

307.7

240

207

Kela drug reimbursment

Chronic arrhythmias

331.8

307.7

1662

C09AA02

ATC

enalapril; systemic

3.0

307.7

1896

6026

T82

ICPC

Obesity

14.8

307.7

747

451

I25.2

ICD-10 Finland

Old myocardial infarction

1440.1

307.7

779

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

2798

WX722

NOMESCO Finland

PEEP

+∞

307.7

10006

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.8

307.7

611

685

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

16.7

307.7

824

446

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.4

307.7

795

1115

J45.9

ICD-10 Finland

Asthma, unspecified

3.4

307.7

2207

6397

WX725

NOMESCO Finland

Noninvasive ventilation

+∞

307.7

593

A10BD07

ATC

metformin and sitagliptin; systemic

+∞

307.7

438

C10AA01

ATC

simvastatin; oral

3.5

307.7

4333

14988

A10BJ02

ATC

liraglutide; parenteral

203.8

307.7

511

A10BB12

ATC

glimepiride; oral

417.7

307.7

743

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

82.1

307.7

306

A10AC01

ATC

insulin (human); parenteral

71.5

307.7

762

E66

ICD-10 Finland

Obesity

8.6

307.7

814

849

R03AC02

ATC

salbutamol; inhalant

2.6

307.7

5667

27916

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

8.5

307.7

1028

1105

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

17.6

307.7

531

265

C08CA01

ATC

amlodipine; oral

3.2

307.7

4379

16313

I20.09

ICD-10 Finland

Unstable angina

222.8

307.7

532

R02

ICPC

Shortness of breath/dyspnoea

4.6

307.7

1589

3286

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.7

307.7

2920

3780

C03CA01

ATC

furosemide; systemic

9.3

307.7

4148

5919

F34.1

ICD-10 Finland

Dysthymia

14.4

307.7

356

213

N03AX16

ATC

[U] pregabalin

3.1

307.7

2562

8412

E66.8

ICD-10 Finland

Other obesity

64.5

307.7

1049

151

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

7.5

307.7

999

1221

I25.1

ICD-10 Finland

Atherosclerotic heart disease

135.2

307.7

2484

203

J01MA12

ATC

levofloxacin; systemic

3.0

307.7

2214

7245

I25

ICD-10 Finland

Chronic ischaemic heart disease

61.7

307.7

473

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.6

307.7

797

1269

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

8.0

307.7

848

957

M04AA01

ATC

allopurinol; systemic

5.3

307.7

1722

3134

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

14.2

307.7

461

282

215

Kela drug reimbursment

Diabetes, non-insulin-treated

13968.0

307.7

3388

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

35.3

307.7

411

101

N06AX21

ATC

duloxetine; oral

3.9

307.7

1139

2669

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

28.6

307.7

251

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

5.1

307.7

2252

4488

TFP34

NOMESCO Finland

Electrophysiological investigation

105.1

307.7

198

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

27.0

307.7

402

129

N02AX02

ATC

tramadol; systemic, rectal

2.6

307.7

4730

21298

B01AC04

ATC

clopidogrel; oral

12.0

307.7

1681

1384

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.0

307.7

1053

2364

103

Kela drug reimbursment

Diabetes, insulin-treated

2305.8

307.7

3678

A46

ICD-10 Finland

Erysipelas

3.3

307.7

1743

4943

P06

ICPC

Sleep disturbance

4.0

307.7

1666

3974

TPH07

NOMESCO Finland

Cathetrisation of artery

7.9

307.7

1936

2471

XG466

NOMESCO Finland

Sleep oxymetry

40.6

307.7

1442

344

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3357.3

307.7

764

C01DA14

ATC

isosorbide mononitrate; oral

28.8

307.7

1705

591

E66.9

ICD-10 Finland

Obesity, unspecified

38.2

307.7

568

131

TPH04

NOMESCO Finland

Cathetrisation of vein

4.6

307.7

2884

6724

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

96.5

307.7

741

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.6

307.7

2435

3862

N06AX11

ATC

mirtazapine; oral

2.6

307.7

3109

12457

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

65.7

307.7

445

E66.00

ICD-10 Finland

Metabolic syndrome

25.8

307.7

1140

413

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

14.8

307.7

357

208

160

Kela drug reimbursment

exenatide

+∞

307.7

337

Z2446

NOMESCO Finland

Social worker

7.1

307.7

1036

1329

RK320, ,

NOMESCO Finland

38.3

307.7

411

C01BD01

ATC

amiodarone; systemic

1065.8

307.7

370

B01AF02

ATC

apixaban; oral

14.5

307.7

1385

911

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

7.1

307.7

972

1247

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

6.7

307.7

1891

2813

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

45.8

307.7

532

102

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

11.1

307.7

2994

3090

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

48.3

307.7

554

101

TKC20

NOMESCO Finland

Catheterisation of bladder

7.4

307.7

1308

1666

I50.9

ICD-10 Finland

Heart failure, unspecified

28.7

307.7

2222

822

I50.1

ICD-10 Finland

Left ventricular failure

54.1

307.7

690

114

A10BK03

ATC

empagliflozin; oral

258.4

307.7

1226

C01AA05

ATC

digoxin; systemic

31.2

307.7

801

232

XG410

NOMESCO Finland

Flow-volume spirometry

9.1

307.7

700

686

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

64.7

307.7

228

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

83.0

307.7

679

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.8

307.7

917

1414

SPAT1263

SPAT

Sampling

2.6

307.7

3971

17052

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.8

307.7

495

489

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.2

307.7

3320

8747

N06AX16

ATC

venlafaxine; oral

4.8

307.7

1362

2672

E66.01

ICD-10 Finland

Obesity due to excess calories

25.2

307.7

1850

744

R06.0

ICD-10 Finland

Dyspnoea

5.2

307.7

3461

7679

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.8

307.7

1549

2545

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.3

307.7

1593

4517

XF402

NOMESCO Finland

ECG with work load test

8.7

307.7

1333

1452

C10AA05

ATC

atorvastatin; oral

3.4

307.7

4543

16551

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

101.9

307.7

631

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

19.2

307.7

761

355

SPAT1262

SPAT

Handing over of treatment supplies

11.2

307.7

2348

2226

R5140

NOMESCO Finland

Monitoring the use of the aid

18.1

307.7

4216

3225

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

1060

R04

ICPC

Breathing problem other

7.8

307.7

798

910

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

988.2

307.7

1679

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

29.3

307.7

448

133

A02BC02

ATC

pantoprazole; systemic

2.9

307.7

7117

38269

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

102.1

307.7

309

L28

ICPC

Limited function/disability (L)

3.4

307.7

2216

6387

N06AB04

ATC

citalopram; systemic

4.0

307.7

2125

5207

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

307.7

458

K77

ICPC

Heart failure

31.3

307.7

253

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

307.7

483

C07AB07

ATC

bisoprolol; oral

7.6

307.7

5599

11922

A10BB01

ATC

glibenclamide; oral

184.1

307.7

321

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

899.1

307.7

609

TFP20

NOMESCO Finland

Cardiodefibrillation

357.9

307.7

828

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.7

307.7

1378

2255

WX892

NOMESCO Finland

Monitored bed care

13.3

307.7

1458

1057

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.0

307.7

2649

2909

H02AB06

ATC

prednisolone; systemic

2.5

307.7

5067

24416

Z3226

NOMESCO Finland

Physiotherapist

3.9

307.7

2526

6652

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

14.3

307.7

3087

2518

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

307.7

408

N05AH04

ATC

quetiapine; oral

4.0

307.7

1484

3463

ZX120

NOMESCO Finland

Intravenous

4.4

307.7

1491

3185

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

3.1

307.7

1659

5039

XF404

NOMESCO Finland

Ambulatory ECG

13.6

307.7

990

667

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

26.8

307.7

260

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.3

307.7

2861

4333

K78

ICPC

Atrial fibrillation/flutter

37.9

307.7

724

171

OAB50, ,

SPAT

8.7

307.7

1027

1083

I49.5

ICD-10 Finland

Sick sinus syndrome

190.9

307.7

311

WX730

NOMESCO Finland

Conventional respirator

38.3

307.7

536

123

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

15.4

307.7

347

194

AN1

Coronary angiography

216.9

307.7

1112

A10AB05

ATC

insulin aspart; parenteral

137.0

307.7

858

Z2221

NOMESCO Finland

Medical doctor

3.3

307.7

3427

11425

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

53.5

307.7

695

116

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

946.0

307.7

435

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

980

Z01.8

ICD-10 Finland

Other specified special examinations

3.1

307.7

2594

8442

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.2

307.7

1080

2359

N17.9

ICD-10 Finland

Acute renal failure, unspecified

8.4

307.7

543

563

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.4

307.7

1854

5240

G47.3

ICD-10 Finland

Sleep apnoea

29.5

307.7

7653

8271

Z3231

NOMESCO Finland

Registered nurse

4.0

307.7

3779

10938

205

Kela drug reimbursment

Chronic hypertension

4.1

307.7

2885

7485

A10BA02

ATC

metformin; oral

115.5

307.7

3868

452

XF400

NOMESCO Finland

ECG with 12 standard connections

8.1

307.7

2682

3584

I49.3

ICD-10 Finland

Ventricular premature depolarization

7.6

307.7

562

644

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.6

307.7

1378

3495

R03BB04

ATC

tiotropium bromide; inhalant

5.7

307.7

1456

2419

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

62.9

307.7

550

ZXD05

NOMESCO Finland

Urgent procedure

3.2

307.7

3203

10575

WX872

NOMESCO Finland

Intensive care

19.5

307.7

731

336

B01AC24

ATC

ticagrelor; oral

252.2

307.7

294

I50

ICD-10 Finland

Heart failure

40.4

307.7

485

105

M10.9

ICD-10 Finland

Gout, unspecified

5.5

307.7

904

1473

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

8.9

307.7

837

850

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.0

307.7

664

979

Z3229

NOMESCO Finland

Other healthcare associate professional

4.5

307.7

1271

2613

C09AA05

ATC

ramipril; oral

4.8

307.7

2761

6121

C02AC05

ATC

moxonidine; oral

7.4

307.7

561

662

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

29.9

307.7

574

169

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

165.9

307.7

1391

N06AX12

ATC

bupropion; oral

7.0

307.7

679

852

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.7

307.7

1650

4272

R06.5

ICD-10 Finland

Mouth breathing

3.6

307.7

1377

3493

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

29.5

307.7

756

230

A10BK01

ATC

dapagliflozin; oral

171.0

307.7

1065

SPAT1054

SPAT

Examination of peripheral nervous system

55.6

307.6

203

R53

ICD-10 Finland

Malaise and fatigue

2.6

307.4

2294

8514

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.2

306.4

1464

4262

I20.00

ICD-10 Finland

Unstable angina

2625.3

304.0

314

R01AD09

ATC

mometasone; nasal

2.2

303.4

4761

24411

N05AX12

ATC

aripiprazole; systemic

23.8

301.4

246

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

42.9

298.6

207

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.7

296.0

2070

7423

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.4

295.9

832

1676

I47.1

ICD-10 Finland

Supraventricular tachycardia

20.2

294.9

256

108

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.7

292.7

2001

7090

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.8

290.8

736

1359

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

7.2

287.7

474

573

F29

ICD-10 Finland

Unspecified nonorganic psychosis

70.5

287.5

183

N06AB03

ATC

fluoxetine; oral

3.7

287.0

1046

2553

N05CF01

ATC

zopiclone; oral

2.3

283.7

2959

12750

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

371.3

283.2

304

SPAT1216

SPAT

Assessment of functional ability

3.0

283.1

1542

4831

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

5.0

282.4

682

1209

B01AF01

ATC

rivaroxaban; oral

3.3

281.1

1260

3518

J01FF01

ATC

clindamycin; systemic

2.4

280.7

2764

11607

SPAT1104

SPAT

Monitoring of emergency patient

4.6

280.2

745

1433

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.2

279.8

461

557

N05AA02

ATC

levomepromazine; systemic

11.3

278.8

326

248

A10BG03

ATC

pioglitazone; oral

506.7

278.7

296

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

32.3

276.0

205

B01AC06

ATC

acetylsalicylic acid; oral

33.6

275.1

202

C08DB01

ATC

diltiazem; oral

6.8

272.9

470

597

A02BC05

ATC

esomeprazole; systemic

2.1

271.7

3922

19230

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

58.0

271.6

178

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

270.9

2753

11693

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

7.5

270.3

429

496

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

14.5

269.8

273

161

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

807.6

269.6

283

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.4

269.6

2414

9694

S97

ICPC

Chronic ulcer skin

4.9

266.7

660

1194

P76

ICPC

Depressive disorder

6.4

266.5

489

665

A10AE06

ATC

insulin degludec; parenteral

2264.3

263.8

273

N05AH03

ATC

olanzapine; systemic

7.9

263.6

400

438

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

4.4

263.4

745

1505

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.2

262.8

787

1662

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

34.5

261.8

191

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.8

261.7

897

2093

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

260.3

1304

3884

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.4

259.7

2452

10061

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.1

259.1

1249

3636

A08

ICPC

Swelling

4.5

257.1

693

1346

WX002

NOMESCO Finland

Sedation and analgesia

2.5

255.9

2085

7996

C08CA13

ATC

lercanidipine; oral

2.9

254.5

1458

4680

J01DB01

ATC

cefalexin; oral

2.4

253.2

8144

53622

A28

ICPC

Limited function/disability NOS

2.7

252.7

1593

5380

N03AX09

ATC

lamotrigine; oral

7.4

252.6

402

466

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

754.7

252.0

265

P03

ICPC

Feeling depressed

4.4

252.0

715

1447

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.5

250.9

450

597

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

+∞

250.5

257

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

249.5

256

K90

ICPC

Stroke/cerebrovascular accident

19.2

247.2

219

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

247.0

5211

29104

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

9.5

246.0

322

290

UJF32

NOMESCO Finland

Coloscopy

2.3

243.9

2542

10843

B01AB05

ATC

enoxaparin; parenteral

2.2

243.6

3008

13750

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

39.1

241.7

171

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

54.1

241.3

160

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

240.7

247

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

719.6

240.3

253

R5110, ,

SPAT

3.3

239.7

1036

2816

SPAT1240

SPAT

Therapeutic discussion

4.0

238.0

748

1636

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

12.7

237.7

258

173

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

236.5

1019

2764

ZXE20

NOMESCO Finland

More than three and less than five hours

2.9

236.1

1343

4284

XF640, ,

NOMESCO Finland

10.7

235.9

285

228

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

235.8

242

SPAT1097

SPAT

Recording of ECG

3.0

235.8

1229

3734

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

358.5

235.3

253

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

234.5

4295

22676

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

6.4

234.0

430

585

177

Kela drug reimbursment

Insulin glargine 300 U / ml

+∞

233.9

240

N06AB06

ATC

sertraline; oral

3.6

233.2

856

2090

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

14.8

233.2

233

134

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

9.7

233.0

301

266

SPAT1229

SPAT

Assessment of need for aid

3.9

232.5

772

1757

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

86.9

232.0

144

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.7

231.6

826

1977

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1976.0

231.5

240

RK110, ,

NOMESCO Finland

17.0

231.2

216

108

N19

ICD-10 Finland

Unspecified kidney failure

6.5

230.3

415

553

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

+∞

230.0

236

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.6

229.9

612

1175

N02BE01

ATC

paracetamol; systemic, rectal

2.6

229.4

8703

59867

XA420

NOMESCO Finland

Extensive sleep examination

12.3

228.2

253

176

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

10.0

226.8

287

246

C08CA02

ATC

felodipine; oral

3.5

226.8

904

2331

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.8

226.6

561

1013

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

+∞

226.0

232

I20.01

ICD-10 Finland

Unstable angina

1923.8

225.7

234

SPAT1310

SPAT

Counselling related to known health issue

2.2

225.3

2666

11922

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

5.1

224.3

518

880

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.2

223.9

2741

12418

N05CD07

ATC

temazepam; oral

3.2

223.9

1015

2837

N06AX26

ATC

vortioxetine; oral

4.6

223.7

591

1127

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

223.4

4142

21858

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

222.1

228

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.4

221.8

918

2424

WX890

NOMESCO Finland

Intesive care monitoring

38.8

220.1

156

C09CA01

ATC

losartan; oral

2.2

219.8

2487

10908

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

17.2

218.7

203

100

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

5.7

218.1

443

667

AN3

Balloon angioplasty and metallic stent

+∞

217.2

223

A04

ICPC

Weakness/tiredness general

2.7

216.9

1347

4491

F61.0

ICD-10 Finland

Mixed personality disorders

54.9

216.2

143

N05BA01

ATC

diazepam; systemic, rectal

3.0

214.3

1071

3169

C07AG02

ATC

carvedilol; oral

4.7

213.9

550

1025

A10AB04

ATC

insulin lispro; parenteral

223.1

213.5

235

C07AA07

ATC

sotalol; systemic

9.6

212.9

276

245

XF600

NOMESCO Finland

Bloodpressure measurement

4.0

212.1

660

1430

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

210.4

1426

4966

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1784.9

210.0

218

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

209.8

744

1771

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

626.3

209.2

221

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.0

208.9

3931

20723

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.5

208.7

1628

6065

R4110, ,

SPAT

2.5

207.3

1553

5676

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

26.9

206.9

162

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

29.0

206.6

158

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.2

206.4

609

1267

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

5.9

204.6

405

594

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

204.4

3200

15796

5CM18, ,

NOMESCO Finland

239.5

204.3

224

A10AA02, ,

ATC

909.8

204.2

214

I44.2

ICD-10 Finland

Atrioventricular block, complete

10.6

204.1

248

200

A02BC01

ATC

omeprazole; systemic

2.2

203.4

2363

10431

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

28.7

203.2

156

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1724.3

203.2

211

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1715.7

202.2

210

R03BA05

ATC

fluticasone; inhalant

2.3

201.2

1822

7251

A06AD11

ATC

lactulose; oral

2.6

200.2

1324

4548

R4120

NOMESCO Finland

Occupational therapy

3.6

200.1

748

1844

AN4

Balloon angioplasty and drug eluding stent

+∞

198.6

204

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.6

198.6

518

976

R95

ICPC

Chron obstructive pulmonary disease

6.2

198.0

368

506

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.4

197.7

818

2155

N07BB01

ATC

disulfiram; oral

6.3

197.4

366

502

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.3

197.3

831

2214

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.3

197.2

844

2271

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.9

196.8

640

1431

AA1

Conventional CABG

+∞

195.7

201

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.1

195.4

448

755

L17

ICPC

Foot/toe symptom/complaint

2.0

195.1

2835

13585

A11CC03

ATC

alfacalcidol; systemic

7.6

193.0

301

340

N06AA09

ATC

amitriptyline; systemic

3.3

192.5

838

2278

I47.2

ICD-10 Finland

Ventricular tachycardia

256.9

192.2

210

A10BX07

ATC

[U] liraglutide

+∞

191.8

197

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

6.5

191.8

342

450

1CX08, ,

NOMESCO Finland

849.0

190.5

200

N05BA12

ATC

alprazolam; oral

3.1

189.9

879

2480

F41.1

ICD-10 Finland

Generalized anxiety disorder

7.3

189.1

304

356

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

565.4

188.7

200

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

15.2

188.7

186

104

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.2

187.1

547

1129

XG474

NOMESCO Finland

Exhalation nntrogen oxide

5.8

187.0

372

548

H02AB04

ATC

methylprednisolone; systemic

2.4

186.5

1488

5580

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

17.3

186.0

172

F32

ICD-10 Finland

Depressive episode

5.1

185.7

431

734

E87.5

ICD-10 Finland

Hyperkalaemia

12.4

185.3

204

140

C10AA04

ATC

fluvastatin; oral

3.5

185.0

724

1838

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

183.9

999

3088

TK810

NOMESCO Finland

Hemofiltration

33.5

183.7

135

R42

ICD-10 Finland

Dizziness and giddiness

2.2

183.1

1977

8435

C09BA02

ATC

enalapril and diuretics; systemic

3.3

181.9

758

2003

B01AC07

ATC

dipyridamole; systemic

7.2

181.2

296

353

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

181.1

6798

43984

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

181.1

186

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.6

180.6

668

1633

F10.09

ICD-10 Finland

Alcohol intoxication UNS

73.9

180.0

114

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.5

179.9

1372

5033

RD210, ,

NOMESCO Finland

8.8

179.8

249

242

G47.9

ICD-10 Finland

Sleep disorder, unspecified

5.1

179.5

413

698

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

+∞

179.1

184

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

6.0

179.1

345

492

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

178.6

1178

4028

RK510, ,

NOMESCO Finland

73.2

178.2

113

ZXA00

NOMESCO Finland

Right side

2.0

178.2

2591

12353

3AC01, ,

NOMESCO Finland

14.2

177.0

180

107

Single vessel balloon catheter extension

+∞

176.2

181

N18.0

ICD-10 Finland

End-stage renal disease

17.7

175.7

161

RK250, ,

NOMESCO Finland

21.8

174.7

147

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

30.1

174.4

132

ZXA05

NOMESCO Finland

Left side

2.0

174.3

2414

11297

162

Kela drug reimbursment

liraglutide

+∞

174.2

179

M79.6

ICD-10 Finland

Pain in limb

1.8

174.2

4077

22704

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.9

174.1

565

1260

SPAT1211

SPAT

Application of soft bandage

3.0

174.0

872

2573

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

173.7

2830

14016

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.2

173.4

511

1060

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.3

173.3

496

1006

4019X

ICD-9 Finland

Essential hypertension, Unspecified

9.6

173.2

224

198

N05AB03

ATC

perphenazine; systemic, rectal

10.3

173.1

213

175

RK520, ,

NOMESCO Finland

18.9

172.8

154

J96.9

ICD-10 Finland

Respiratory failure, unspecified

30.5

172.4

130

C09DA01

ATC

losartan and diuretics; oral

2.7

172.3

1086

3626

J81

ICD-10 Finland

Pulmonary oedema

46.9

171.9

117

J01DA01

ATC

[U] cefalexin

1.8

171.4

5654

34860

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

10.0

170.5

214

181

A02BA02

ATC

ranitidine; systemic

2.3

170.2

1646

6694

N05AF03

ATC

chlorprothixene; systemic

21.3

169.8

144

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

88.4

169.4

105

AP1

Catheterization of the left side of the heart

507.6

169.3

180

R4190

NOMESCO Finland

Nutritional therapy

4.0

169.1

520

1114

SPAT1051

SPAT

Guidance regarding sleep disorders

8.5

169.0

240

241

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.3

168.6

726

1956

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

168.6

2121

9566

DHB50

NOMESCO Finland

Turbinoplasty

4.8

168.2

414

742

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

167.4

172

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.8

167.3

560

1276

H25.8

ICD-10 Finland

Other senile cataract

2.6

167.1

1144

3978

3051, ,

Kela drug reimbursment

34.3

167.0

122

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

166.4

1586

6406

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

12.3

165.9

183

126

A99

ICPC

Disease/condition unspecnature/site

2.6

165.6

1073

3630

C08DA01

ATC

verapamil; systemic

5.9

165.6

326

475

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.9

165.3

530

1171

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

165.1

1925

8429

J01AA02

ATC

doxycycline; systemic

1.9

164.2

7520

50951

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.2

163.6

709

1917

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

163.6

1250

4578

J01CA04

ATC

amoxicillin; systemic

2.0

163.5

7772

53266

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

41.7

163.5

114

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

1496.5

163.2

170

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.5

163.1

434

830

UKC02

NOMESCO Finland

Cystoscopy

2.3

163.0

1546

6228

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

162.4

3551

19258

Z49.1

ICD-10 Finland

Extracorporeal dialysis

12.9

162.3

174

114

A10AA01, ,

ATC

1486.3

162.3

169

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

17.5

161.8

149

B01AE07

ATC

dabigatran etexilate; oral

6.7

161.1

280

358

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

160.8

2378

11345

RK290, ,

NOMESCO Finland

37.3

160.7

115

A10BX01

ATC

guar gum; oral

7.2

160.6

262

312

J46

ICD-10 Finland

Status asthmaticus

5.9

160.1

311

447

R03DA04

ATC

theophylline; systemic, rectal

3.8

159.9

527

1187

K84

ICPC

Heart disease other

11.3

159.8

186

140

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

11.7

159.3

181

131

WX704

NOMESCO Finland

Intubation

3.4

159.3

642

1658

M10.0

ICD-10 Finland

Idiopathic gout

4.9

159.1

383

673

R03BA02

ATC

budesonide; inhalant

2.2

158.8

1674

7035

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

158.5

1709

7246

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.6

158.3

245

274

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.9

158.1

307

441

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

358.4

158.1

170

M54.5

ICD-10 Finland

Low back pain

1.8

158.0

3265

17365

N05BE01

ATC

buspirone; oral

7.7

157.7

242

268

E66.0

ICD-10 Finland

Obesity due to excess calories

210.7

157.6

174

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

157.6

162

A10BH02

ATC

vildagliptin; oral

697.6

156.5

165

R01AD08

ATC

fluticasone; nasal

1.9

156.3

2752

13903

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.7

156.2

240

266

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

9.9

156.1

197

168

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

155.9

1764

7617

K76

ICPC

Ischaemic heart dis without angina

27.6

155.8

121

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.7

155.3

546

1287

RS221, ,

NOMESCO Finland

9.2

155.2

207

191

C10AA07

ATC

rosuvastatin; oral

1.9

155.0

3060

16025

Z2445

NOMESCO Finland

Psychologist

5.6

154.8

319

486

IGY99

NOMESCO Finland

Other psychiatric treatment contact

10.3

153.7

190

157

Coronary artery bypass surgery

+∞

153.7

158

K99

ICPC

Cardiovascular disease other

7.8

153.5

232

252

WW804

NOMESCO Finland

Transfer from treating institution to higher-Level care, accompanied by doctor

53.6

153.5

102

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

153.2

983

3304

N03AG01

ATC

valproic acid; systemic, rectal

4.2

152.7

449

929

R99

ICPC

Respiratory disease other

6.6

152.7

269

349

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

680.4

152.6

161

J01FA06

ATC

roxithromycin; oral

1.8

152.0

3565

19653

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.9

151.6

824

2538

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.0

151.3

476

1036

F10.20

ICD-10 Finland

Alcohol dependence currently independent

21.2

150.5

128

N06AA12

ATC

doxepin; systemic

4.3

149.9

427

862

R00.1

ICD-10 Finland

Bradycardia, unspecified

6.6

149.8

263

340

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

67.3

149.6

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

79.0

149.6

R2110

NOMESCO Finland

Giving the first information

3.2

149.5

666

1829

N03AX12

ATC

[U] gabapentin; oral

2.3

149.2

1295

5010

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

18.7

148.8

133

R03AK03

ATC

[U] fenoterol and ipratropium bromide

3.7

148.3

524

1239

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

5.7

148.2

302

455

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.2

148.0

668

1849

J45

ICD-10 Finland

Asthma

2.5

147.8

1024

3572

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

14.3

146.9

149

J01MA02

ATC

ciprofloxacin; systemic

1.8

146.7

3580

19915

J45.1

ICD-10 Finland

Nonallergic asthma

3.1

146.6

688

1949

A02BC03

ATC

lansoprazole; oral

1.9

146.5

2352

11488

M10

ICD-10 Finland

Gout

3.8

146.4

495

1135

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

146.0

1308

5127

A41.9

ICD-10 Finland

Sepsis, unspecified

4.7

145.9

369

676

A10BX04

ATC

[U] exenatide

+∞

145.9

150

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.8

145.4

289

425

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

145.1

3091

16503

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.2

144.8

235

278

IGY02

NOMESCO Finland

Psychiatric monitoring contact

8.9

144.8

198

189

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

144.5

966

3310

F10.25

ICD-10 Finland

Alcohol dependence continuous use

28.3

144.1

111

K07

ICPC

Swollen ankles/oedema

4.0

143.8

443

949

R06.2

ICD-10 Finland

Wheezing

3.7

143.8

496

1153

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

17.3

143.7

133

N02AA05

ATC

oxycodone; systemic

2.1

143.6

1707

7489

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

6.4

143.3

260

348

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

11.3

143.3

166

124

AN2

Balloon angioplasty, including several vessels

+∞

143.0

147

F41.00

ICD-10 Finland

Moderate panic disorder

36.1

142.8

103

P01AB01

ATC

metronidazole; oral, rectal

1.8

142.1

3522

19636

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

141.9

1125

4176

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

1275.2

141.8

148

R04.0

ICD-10 Finland

Epistaxis

3.1

141.7

654

1834

SPAT1325

SPAT

Vaccination

1.8

141.6

2845

14902

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

12.7

141.3

153

102

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

8.5

141.2

200

Z02.7

ICD-10 Finland

Issue of medical certificate

3.0

140.4

677

1947

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.5

140.4

1018

3625

P01

ICPC

Feeling anxious/nervous/tense

2.9

140.2

714

2119

C10AA03

ATC

pravastatin; oral

3.4

140.1

568

1470

NHQ40

NOMESCO Finland

Amputation of toe

10.3

139.9

172

141

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.7

139.8

483

1124

R07.3

ICD-10 Finland

Other chest pain

2.7

139.0

837

2719

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

73.9

138.9

ZXE00

NOMESCO Finland

One hour or less

1.8

138.6

3377

18705

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.5

138.4

1010

3607

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

2.2

137.9

1386

5690

SPAT1234

SPAT

Support of social functional capacity

4.0

137.8

425

911

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

137.4

3060

16501

R51.80

ICD-10 Finland

Headache

2.3

137.4

1213

4717

J01MA14

ATC

moxifloxacin; systemic

2.6

136.8

890

3006

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

5.6

136.7

279

421

WX320

NOMESCO Finland

Spinalanesthesy

1.9

136.4

2418

12155

A10AD05

ATC

insulin aspart; parenteral

253.5

136.3

149

N18.8

ICD-10 Finland

Other chronic renal failure

7.1

135.7

222

265

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.1

135.5

401

833

J37.0

ICD-10 Finland

Chronic laryngitis

4.2

135.5

393

804

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

135.4

3364

18708

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

9.0

134.6

182

171

A10BJ01

ATC

exenatide; parenteral

+∞

134.2

138

M79.7

ICD-10 Finland

Fibromyalgia

5.2

133.7

301

498

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

12.4

133.5

146

WX723

NOMESCO Finland

CPAP therapy

3.4

133.0

520

1314

C09CA03

ATC

valsartan; oral

2.6

132.9

863

2911

R96

ICPC

Asthma

2.6

132.8

898

3089

ZXE90

NOMESCO Finland

More than 22 hours

18.6

132.8

119

A10BD03

ATC

metformin and rosiglitazone; systemic

+∞

132.2

136

F99

ICD-10 Finland

Mental disorder, not otherwise specified

10.6

132.2

160

128

B01AF03

ATC

edoxaban; oral

22.9

132.1

109

C09CA06

ATC

candesartan; oral

1.9

132.0

2288

11404

F32.1

ICD-10 Finland

Moderate depressive episode

4.5

131.8

349

664

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

27.7

131.5

102

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

585.9

131.3

139

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

131.3

135

WNF00

NOMESCO Finland

Infection source and contact determination

25.7

131.0

104

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

15.5

130.6

127

R05FB02

ATC

cough suppressants and expectorants; systemic

1.7

130.0

3329

18624

M48.0

ICD-10 Finland

Spinal stenosis

2.3

129.3

1100

4204

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

13.3

129.3

136

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

26.0

129.0

102

N02BF02

ATC

pregabalin; oral

3.0

128.9

638

1861

RS220, ,

NOMESCO Finland

8.6

128.9

181

179

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.3

128.8

1131

4382

ZY010

NOMESCO Finland

Hospital outpatient

4.2

128.2

372

761

R03DC03

ATC

montelukast; oral

2.1

127.4

1482

6426

F41.09

ICD-10 Finland

UNS Panic Syndrome

9.5

126.8

165

147

XG460

NOMESCO Finland

Short time oxymetry

7.2

126.5

205

242

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

19.5

126.3

111

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

7.7

126.0

193

213

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

126.0

2679

14183

L03

ICPC

Low back symptom/complaint

1.8

126.0

2495

12932

R32

ICD-10 Finland

Unspecified urinary incontinence

4.6

125.0

318

585

N03AE01

ATC

clonazepam; systemic

3.5

124.7

469

1155

XKD00

NOMESCO Finland

Uroflowmetry

2.0

124.6

1585

7098

NG2AA

NOMESCO Finland

Patella X-ray examination

3.9

124.2

393

858

N04BC05

ATC

pramipexole; oral

2.7

124.1

740

2388

RK120, ,

NOMESCO Finland

19.8

123.6

108

F60.9

ICD-10 Finland

Personality disorder, unspecified

34.4

123.3

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.8

123.1

302

539

M01AB01

ATC

indometacin; systemic, rectal

2.7

122.8

739

2395

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

10.9

122.5

145

112

H3601, E113,

ICD-10 Finland

+∞

122.5

126

I20.91

ICD-10 Finland

Angina pectoris, unspecified

1079.8

122.4

128

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

122.3

581

1654

R03BB01

ATC

ipratropium bromide; inhalant

4.0

121.3

377

812

R55

ICD-10 Finland

Syncope and collapse

2.5

121.3

854

2991

A12AA04

ATC

calcium carbonate; oral

8.2

121.1

176

182

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.8

120.9

2585

13680

N05BA06

ATC

lorazepam; systemic, sublingual

3.6

120.8

427

1008

A08AB01

ATC

orlistat; oral

38.0

120.7

SPAT1100

SPAT

Long-term monitoring of blood pressure

3.1

120.5

542

1494

280

Kela drug reimbursment

Clopidogrel

1062.0

120.4

126

A10BG02

ATC

rosiglitazone; oral

1062.0

120.4

126

R50.9

ICD-10 Finland

Fever, unspecified

2.1

120.0

1352

5782

Z49.0

ICD-10 Finland

Preparatory care for dialysis

11.1

119.8

140

106

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

119.7

5051

31994

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.8

119.1

290

514

N06AB05

ATC

paroxetine; oral

3.5

119.1

445

1091

250, ,

Kela drug reimbursment

221.6

119.1

131

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

18.4

118.9

107

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

+∞

118.6

122

N06AX03

ATC

mianserin; oral

4.2

118.3

338

683

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

43.0

118.3

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

3.9

118.0

375

821

J20

ICD-10 Finland

Acute bronchitis

2.3

117.8

985

3730

SPAT1281

SPAT

Other administrative function

2.8

117.7

657

2046

K28

ICPC

Limited function/disability (K)

6.8

117.4

200

250

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.5

117.2

432

1049

G04CA02

ATC

tamsulosin; oral

1.8

117.2

2220

11317

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.7

116.9

680

2164

K05.31

ICD-10 Finland

Periodontitis pronounced

2.3

116.9

1051

4104

K91

ICPC

Cerebrovascular disease

17.7

116.8

107

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.5

116.8

434

1060

K29

ICPC

Cardiovascular sympt/complt other

3.8

116.3

380

849

R60.9

ICD-10 Finland

Oedema, unspecified

3.1

116.0

523

1443

B03XA02

ATC

darbepoetin alfa; parenteral

5.5

115.9

243

376

ZY000

NOMESCO Finland

Hospital inpatient

15.7

115.9

112

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.0

115.9

568

1646

Catheterization and pressure measurement of the left side of the heart

58.0

115.8

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.1

115.7

1359

5898

N05AN01

ATC

lithium; oral

10.7

115.7

139

110

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.9

115.1

277

486

I20

ICD-10 Finland

Angina pectoris

14.7

115.0

115

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.9

114.8

582

1719

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

9.7

114.8

147

128

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

261.4

114.7

125

C09DA06

ATC

candesartan and diuretics; oral

2.6

114.5

744

2505

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

11.2

114.3

133

100

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

12.6

114.2

124

K03.66

ICD-10 Finland

Tooth plaque

2.4

113.8

842

3016

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

113.7

117

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

113.6

3309

19007

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

12.6

113.5

123

R03AC13

ATC

formoterol; inhalant

3.3

113.4

476

1257

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.6

113.3

232

351

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

113.1

1101

4441

WX900

NOMESCO Finland

Resuscitation

32.1

113.0

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

504.5

112.9

120

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

112.8

116

N06AG02

ATC

moclobemide; oral

4.0

112.8

343

727

C08CA05

ATC

nifedipine; systemic

3.2

112.7

477

1266

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

52.4

112.3

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

259.0

111.8

122

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.9

111.5

360

797

WW200

NOMESCO Finland

Immunization

4.1

111.5

336

707

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

111.3

2015

10109

V03AE01

ATC

polystyrene sulfonate; oral

9.7

111.3

142

123

R31

ICD-10 Finland

Unspecified haematuria

2.3

111.3

932

3528

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.1

111.2

251

416

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

6.7

111.1

191

241

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

150.6

110.8

125

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.6

110.8

393

930

M01AE02

ATC

naproxen; oral, rectal

1.6

110.7

5143

33101

Z72.0

ICD-10 Finland

Tobacco use

5.6

110.7

225

338

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.9

110.1

346

751

C09AA04

ATC

perindopril; oral

3.3

110.1

456

1194

P15

ICPC

Chronic alcohol abuse

6.1

109.7

205

283

R4140

NOMESCO Finland

Psychotherapy

40.4

109.5

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

109.5

871

3222

R11

ICD-10 Finland

Nausea and vomiting

2.7

109.4

661

2144

R05

ICD-10 Finland

Cough

1.8

109.0

1968

9857

C08CA07

ATC

nisoldipine; oral

25.2

108.9

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

108.9

112

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

17.5

108.8

100

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

108.8

752

2607

N05AX08

ATC

risperidone; systemic

3.0

108.5

511

1446

R03BA08

ATC

ciclesonide; inhalant

2.4

108.5

804

2880

E10

ICD-10 Finland

Type 1 diabetes mellitus

250.1

108.0

118

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

5.3

107.9

236

380

A10AB06

ATC

insulin glulisine; parenteral

+∞

107.9

111

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

11.8

107.6

121

I20.0

ICD-10 Finland

Unstable angina

44.3

107.4

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

107.3

890

3352

L15

ICPC

Knee symptom/complaint

1.7

107.1

2329

12317

SPAT1252

SPAT

Overall medication plan or its review

3.1

107.1

482

1328

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

6.7

106.4

183

231

RK323, ,

NOMESCO Finland

23.6

106.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

106.3

1746

8483

F31.8

ICD-10 Finland

Other bipolar affective disorders

13.0

106.2

113

EB1MA

NOMESCO Finland

Cephalometry with X-ray

4.6

106.0

275

514

WW500

NOMESCO Finland

Blood transfusion

3.2

106.0

456

1222

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

+∞

105.9

109

C07AB03

ATC

atenolol; systemic

3.5

105.8

397

975

C02EA02, ,

ATC

4.1

105.5

313

651

R05

ICPC

Cough

1.8

105.1

2144

11125

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

+∞

105.0

108

E0000UV, ,

ATC

1.6

104.9

3664

21923

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.4

104.7

187

246

R03AK08

ATC

formoterol and beclometasone; inhalant

3.3

104.6

439

1159

SPAT1301

SPAT

No procedures

1.7

104.5

2285

12092

I45.9

ICD-10 Finland

Conduction disorder, unspecified

18.4

104.5

ZXD00

NOMESCO Finland

Emergency procedure

4.8

104.4

251

440

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.9

104.4

534

1584

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

104.3

1382

6248

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.1

104.2

307

635

K92.1

ICD-10 Finland

Melaena

3.3

104.2

433

1136

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.5

104.1

216

331

H3600, E113,

ICD-10 Finland

+∞

104.0

107

R04.2

ICD-10 Finland

Haemoptysis

4.1

103.6

309

645

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

103.5

2101

10879

H04AA01

ATC

glucagon; nasal, parenteral

140.8

103.2

117

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.9

103.1

531

1581

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

103.1

664

2223

T92

ICPC

Gout

5.5

102.8

216

335

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.2

102.8

295

598

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

102.6

2011

10302

E87.6

ICD-10 Finland

Hypokalaemia

4.2

102.3

295

600

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

20.5

102.3

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.5

102.3

688

2352

R29

ICPC

Respiratory symptom/complaint other

2.6

102.1

637

2098

C07AB08

ATC

celiprolol; oral

5.6

102.1

209

316

NOMESCO Finland

Other rehabilitation services

+∞

102.0

105

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.6

101.4

368

884

SPAT1255

SPAT

Intravenous administration of medicine

2.8

101.1

561

1739

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

101.1

104

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

101.1

104

P99

ICPC

Psychological disorders other

7.5

101.0

158

179

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

9.1

100.9

135

125

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

100.3

1040

4291

A01

ICPC

Pain general/multiple sites

2.4

100.2

794

2929

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

883.0

100.1

105

R03AC12

ATC

salmeterol; inhalant

3.3

99.8

408

1059

F32.8

ICD-10 Finland

Other depressive episodes

12.9

99.8

107

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

55.3

99.7

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

8.7

99.6

138

134

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.9

99.6

522

1569

R03AK11

ATC

formoterol and fluticasone; inhalant

4.2

99.5

282

566

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.2

99.5

947

3776

K74

ICPC

Ischaemic heart dis with angina

35.5

99.4

A10BD20

ATC

metformin and empagliflozin; oral

444.8

99.3

106

N06AX05

ATC

trazodone; oral

6.0

99.3

188

263

AS4

Physiological pacemaker insertion DDD (R)

21.4

99.2

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

99.1

102

PD5BD

NOMESCO Finland

Extensive CT of aorta

7.5

99.1

154

173

J01MA01

ATC

ofloxacin; systemic

2.3

98.6

817

3072

K02.1

ICD-10 Finland

Caries of dentine

1.6

98.6

5207

34149

E86

ICD-10 Finland

Volume depletion

5.6

98.5

202

306

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

98.5

2103

11029

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

98.1

101

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

98.1

101

SPAT1260

SPAT

Consultation of another employee

2.0

97.7

1289

5809

PD5AD

NOMESCO Finland

CT of aorta

5.8

97.7

193

282

P29

ICPC

Psychological sympt/compl other

3.4

97.7

388

989

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

97.6

582

1873

H03AA01

ATC

levothyroxine sodium; systemic

1.8

97.5

1824

9200

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.6

97.4

350

835

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

12.1

97.4

108

PE1AT

NOMESCO Finland

Femoral artery PTA

12.1

97.4

108

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

97.3

794

2965

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

+∞

97.2

100

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

97.1

6024

40911

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.8

97.0

192

281

SPAT1312

SPAT

General health counselling

1.7

96.8

2452

13466

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

96.7

816

3092

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.2

96.5

273

547

A11

ICPC

Chest pain NOS

2.6

96.0

607

2012

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

289.8

95.9

104

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

13.3

95.9

101

XA421

NOMESCO Finland

Nocturnal polygraphy

10.6

95.7

115

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.3

95.5

174

234

K29.3

ICD-10 Finland

Chronic superficial gastritis

4.1

95.4

278

570

A07AA02

ATC

nystatin; oral

2.8

95.0

513

1566

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

31.3

94.9

R35

ICD-10 Finland

Polyuria

2.5

94.8

670

2343

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

94.8

3315

19719

K93

ICPC

Pulmonary embolism

27.0

94.6

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

4.8

94.5

228

401

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

18.3

94.3

F10.24

ICD-10 Finland

Alcohol depence active use

20.6

94.3

C09DX04

ATC

valsartan and sacubitril; oral

831.9

94.2

J01CF05

ATC

flucloxacillin; systemic

2.5

94.2

643

2212

UJD02

NOMESCO Finland

Gastroscopy

3.4

94.2

374

953

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

6.0

93.6

179

253

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

93.3

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

93.1

706

2550

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.3

93.0

201

320

RS230, ,

NOMESCO Finland

23.6

93.0

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.4

93.0

704

2541

R4180, ,

SPAT

11.4

93.0

107

M79.1

ICD-10 Finland

Myalgia

2.0

92.8

1241

5612

R78

ICPC

Acute bronchitis/bronchiolitis

4.6

92.4

237

439

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

11.6

92.4

105

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

7.4

92.3

145

165

RK123, ,

NOMESCO Finland

814.9

92.3

R03AC03

ATC

terbutaline; inhalant

2.0

92.1

1129

4951

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.1

91.9

942

3863

I20.9

ICD-10 Finland

Angina pectoris, unspecified

15.6

91.8

-48

ICPC

Clarification/discussion RFE/demand

4.6

91.6

232

425

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

9.4

91.5

120

108

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

91.5

333

801

L04AA06

ATC

mycophenolic acid; systemic

5.3

91.5

200

322

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

91.4

1187

5313

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

91.3

B03BA03

ATC

hydroxocobalamin; parenteral

2.9

91.1

460

1353

S18

ICPC

Laceration/cut

1.5

91.0

4139

26086

I26

ICD-10 Finland

Pulmonary embolism

23.9

90.9

C03BA11

ATC

indapamide; oral

4.4

90.9

242

462

N06AX22

ATC

agomelatine; oral

7.9

90.8

136

146

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

90.8

685

2468

N05AF01

ATC

flupentixol; systemic

8.3

90.7

130

132

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

19.2

90.5

F33

ICD-10 Finland

Recurrent depressive disorder

7.1

90.5

147

174

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.5

90.5

141

159

R06AE07

ATC

cetirizine; oral

1.6

90.4

3712

22856

A10BX02

ATC

repaglinide; oral

797.9

90.4

C02DE04, ,

ATC

6.0

90.4

172

242

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

18.4

90.0

R01AD58

ATC

fluticasone, combinations; nasal

1.7

89.9

2152

11607

N05AA01

ATC

chlorpromazine; systemic, rectal

23.0

89.7

GD2SN

NOMESCO Finland

Lung ventilation SPECT

23.0

89.7

Z29.8

ICD-10 Finland

Other specified prophylactic measures

3.1

89.4

405

1119

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

7.9

89.2

133

142

A03FA02

ATC

cisapride; oral, rectal

2.5

89.2

591

2003

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

11.6

88.9

101

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

5.7

88.7

179

267

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

88.5

2967

17410

S76

ICPC

Skin infection other

2.8

88.5

494

1535

XQ800

NOMESCO Finland

Prick test

2.4

88.4

644

2283

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

3.1

88.2

409

1146

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

121.4

88.0

101

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

87.9

1886

9866

EBA00

NOMESCO Finland

Extraction of tooth

1.6

87.5

2988

17601

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.8

87.4

287

643

WX290

NOMESCO Finland

Other blockage of nerve

1.5

86.9

3964

24921

5253

FHL

Cardiac lung machine

35.2

86.7

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

764.0

86.5

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

2.1

86.1

927

3871

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.4

86.1

181

281

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

85.9

1014

4381

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.1

85.9

256

534

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

385.1

85.8

I44.1

ICD-10 Finland

Atrioventricular block, second degree

6.9

85.8

144

177

H36.00

ICD-10 Finland

Diabetic background retinopathy

755.5

85.5

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

4.6

85.2

218

403

SPAT1059

SPAT

Spirometry at the office

3.0

85.0

405

1152

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.5

84.9

225

428

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

84.9

1062

4684

W19

ICD-10 Finland

Unspecified fall

2.2

84.9

838

3382

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.0

84.9

1139

5148

JN4AD

NOMESCO Finland

Body CT examination

2.0

84.8

1038

4543

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.2

84.8

359

952

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.8

84.7

281

634

A77

ICPC

Viral disease other/NOS

3.4

84.7

335

851

J34.2

ICD-10 Finland

Deviated nasal septum

2.5

84.7

600

2099

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.9

84.1

141

173

A10AD01

ATC

insulin (human); parenteral

133.1

83.5

C09DA03

ATC

valsartan and diuretics; oral

2.9

83.5

417

1219

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

83.4

655

2401

GD1UN

NOMESCO Finland

Lung circulation SPECT

27.2

83.3

R00.2

ICD-10 Finland

Palpitations

2.5

83.3

556

1890

N40

ICD-10 Finland

Hyperplasia of prostate

1.7

83.3

2109

11514

B01AB04

ATC

dalteparin; parenteral

2.9

83.3

428

1271

CS494

NOMESCO Finland

Other visual field testing

3.5

83.2

304

733

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

82.9

733

2828

K59.1

ICD-10 Finland

Functional diarrhoea

2.8

82.8

461

1430

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

730.0

82.6

T83

ICPC

Overweight

4.8

82.6

201

356

RS222, ,

NOMESCO Finland

7.1

82.6

135

161

TGC00

NOMESCO Finland

Bronchial lavation

3.7

82.5

281

646

R4120, ,

SPAT

5.6

82.1

167

251

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

6.2

82.1

151

205

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.5

81.9

544

1845

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

6.6

81.8

143

184

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

81.7

681

2562

H3603, E103,

ICD-10 Finland

+∞

81.6

F40.1

ICD-10 Finland

Social phobias

8.7

81.3

112

108

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

5.0

81.1

188

319

Z01.2

ICD-10 Finland

Dental examination

1.5

81.1

4155

26657

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

6.8

80.7

136

168

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

+∞

80.6

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

6.4

80.4

144

190

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

80.2

531

1798

ZXA10

NOMESCO Finland

Bilateral

1.8

80.2

1531

7726

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

80.1

2515

14465

AA40B, ,

NOMESCO Finland

12.1

80.1

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

704.6

79.7

XF405

NOMESCO Finland

Symptom ECG

16.6

79.6

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

34.7

79.5

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.3

79.2

637

2359

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

4.3

78.9

216

422

-42

ICPC

Electrical tracing

6.1

78.6

148

206

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.6

78.3

509

1708

F39

ICD-10 Finland

Unspecified mood [affective] disorder

8.9

78.2

106

100

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

9.0

78.0

105

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

147.9

78.0

R4130

NOMESCO Finland

Speech therapy

3.8

78.0

258

581

N05CF02

ATC

zolpidem; oral

1.8

78.0

1331

6492

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

7.1

77.9

127

151

M25.5

ICD-10 Finland

Pain in joint

1.6

77.9

2856

17008

N05AB01

ATC

dixyrazine; systemic

11.3

77.8

ZXC60

NOMESCO Finland

Application of heat

4.1

77.8

227

466

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.7

77.8

454

1443

H3603, E113,

ICD-10 Finland

+∞

77.7

SPAT1058

SPAT

PEF monitoring instruction

2.4

77.5

586

2111

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.5

77.4

285

691

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

77.3

600

2186

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

77.3

4155

26836

F22.0

ICD-10 Finland

Delusional disorder

29.1

77.1

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

24.7

77.1

P74

ICPC

Anxiety disorder/anxiety state

4.2

77.0

218

437

127

Kela drug reimbursment

Transplant complication

5.8

77.0

152

222

J45.8

ICD-10 Finland

Mixed asthma

3.7

76.9

263

606

N17.8

ICD-10 Finland

Other acute renal failure

7.5

76.9

119

133

N18

ICPC

Paralysis/weakness

6.2

76.8

141

191

FXG00

NOMESCO Finland

Insertion and use of IABP

679.2

76.8

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.0

76.8

375

1082

XX3XW, ,

NOMESCO Finland

13.1

76.3

R13

ICD-10 Finland

Dysphagia

2.5

76.2

537

1872

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

3.2

76.1

322

853

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.5

76.1

198

371

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

144.5

76.1

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

75.8

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

75.7

3373

20927

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.7

75.6

104

100

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

75.5

3888

24854

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.7

75.5

426

1330

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

176.3

75.4

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

75.4

6405

45245

OAB72, ,

SPAT

6.3

75.3

137

184

R28

ICPC

Limited function/disability (R)

6.0

75.3

142

198

K08.3

ICD-10 Finland

Retained dental root

2.2

75.0

674

2615

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

5.0

74.9

174

296

FXZ00

NOMESCO Finland

Off-pump cardiac operation

662.2

74.9

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

662.2

74.9

A10BX09

ATC

[U] dapagliflozin

+∞

74.8

X57

ICD-10 Finland

Unspecified privation

4.0

74.7

226

477

M01AB05

ATC

diclofenac; systemic, rectal

1.5

74.5

6176

43353

V03AE02

ATC

sevelamer; oral

19.1

74.5

B81

ICPC

Anaemia vit B12/folate deficiency

3.2

74.4

311

818

M03BX02

ATC

tizanidine; oral

1.5

74.3

5589

38476

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

17.0

74.2

E000001, ,

ATC

1.7

74.1

1576

8182

A02BC04

ATC

rabeprazole; oral

2.2

73.9

708

2819

SPAT1360

SPAT

Extensive global examination

2.4

73.9

563

2034

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.8

73.9

243

545

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

73.8

1470

7492

A10BD15

ATC

metformin and dapagliflozin; oral

+∞

73.8

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

73.8

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

+∞

73.8

SPAT1053

SPAT

Memory test

1.9

73.6

1026

4686

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

73.5

1360

6785

F33.8

ICD-10 Finland

Other recurrent depressive disorders

24.7

73.3

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.9

73.3

233

510

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.6

73.2

264

631

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.3

72.9

302

790

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

72.8

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

72.8

A02BA04

ATC

nizatidine; systemic

2.3

72.8

586

2169

V03AA01, ,

ATC

7.3

72.7

115

132

C07AA05

ATC

propranolol; systemic

1.8

72.6

1350

6743

F31

ICD-10 Finland

Bipolar affective disorder

12.5

72.6

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

72.6

361

1052

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

15.3

72.5

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.4

72.4

282

709

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.0

72.3

137

192

N02BF01

ATC

gabapentin; oral

2.1

72.2

801

3375

R33

ICD-10 Finland

Retention of urine

2.2

72.1

660

2579

SFA10

NOMESCO Finland

One-surface restoration

1.5

72.0

4739

31705

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

71.9

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.7

71.8

244

560

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.2

71.5

308

825

OAB72

NOMESCO Finland

Weight control and weight loss guidance

13.0

71.4

315

Kela drug reimbursment

Clopidogrel

20.0

71.3

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

114.7

71.2

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

8.2

71.1

103

106

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

71.1

2386

13874

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

8.0

71.0

105

111

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.4

71.0

280

710

N06AB08

ATC

fluvoxamine; oral

4.4

71.0

191

368

J43.9

ICD-10 Finland

Emphysema, unspecified

5.5

71.0

148

228

XPX08

NOMESCO Finland

Intraoperative flow measurement

13.5

71.0

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

3.9

70.9

220

473

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

70.9

DAX08

NOMESCO Finland

Fitting of hearing aid

2.3

70.6

569

2107

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

70.5

548

1997

L90

ICPC

Osteoarthrosis of knee

2.2

70.4

657

2587

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.7

70.4

416

1330

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.2

70.3

292

765

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

10.3

70.3

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

10.7

70.2

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

70.2

717

2926

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

9.2

70.2

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

14.7

70.1

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

619.9

70.0

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

69.9

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

69.9

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.4

69.9

502

1765

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.4

69.7

188

363

S10

ICPC

Boil/carbuncle

2.5

69.6

493

1722

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

69.4

5801

40502

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.6

69.4

449

1502

FL1AC

NOMESCO Finland

Left cardioangiography

+∞

69.0

358

Kela drug reimbursment

liraglutide

+∞

69.0

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

32.8

68.9

L16

ICPC

Ankle symptom/complaint

1.9

68.9

960

4380

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.7

68.8

169

302

G04CB01

ATC

finasteride; oral

1.9

68.5

918

4132

N05AH02

ATC

clozapine; systemic

27.7

68.3

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

603.0

68.1

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.5

68.1

251

609

L14

ICPC

Leg/thigh symptom/complaint

2.1

68.0

703

2881

-34

ICPC

Blood test

3.7

68.0

232

534

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

7.3

67.8

108

125

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

9.6

67.8

K80

ICPC

Cardiac arrhythmia NOS

2.5

67.8

466

1605

G04BD12

ATC

mirabegron; oral

1.9

67.6

1020

4773

N18

ICD-10 Finland

Chronic kidney disease

7.2

67.6

109

128

ACC51

NOMESCO Finland

Release of median nerve

2.1

67.6

664

2668

M02AA07

ATC

piroxicam; topical

1.5

67.5

3071

19029

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

8.2

67.4

P72

ICPC

Schizophrenia

25.1

67.4

R5140, ,

SPAT

4.9

67.3

157

268

K30

ICD-10 Finland

Functional dyspepsia

2.0

67.3

859

3802

JN4BD

NOMESCO Finland

Extensive body CT

1.9

66.8

960

4421

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.3

66.7

121

162

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.0

66.7

204

434

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

36.5

66.6

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

36.5

66.6

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

66.6

2041

11596

C07AB12

ATC

nebivolol; oral

3.5

66.5

241

578

WX213

NOMESCO Finland

Lower leg blockade

8.8

66.5

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

23.8

66.2

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

28.5

66.2

H3600, E103,

ICD-10 Finland

+∞

66.0

XF612

NOMESCO Finland

Measurement of central venous pressure

17.9

66.0

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.8

65.9

1046

4973

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

65.8

458

1586

SPAT1172

SPAT

Guidance concerning hydration

4.0

65.8

199

420

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

2.0

65.7

814

3564

M01AB55

ATC

diclofenac, combinations; oral

2.3

65.7

545

2042

SFA30

NOMESCO Finland

Three-surface restoration

1.5

65.6

3827

24868

SPAT1010

SPAT

Ophthalmoscopy

17.0

65.6

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.5

65.6

2685

16257

A10BB07

ATC

glipizide; oral

92.3

65.5

N30.0

ICD-10 Finland

Acute cystitis

1.8

65.4

1174

5793

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.3

65.3

558

2117

L60.0

ICD-10 Finland

Ingrowing nail

2.6

65.2

396

1283

F20.9

ICD-10 Finland

Schizophrenia, unspecified

201.3

65.2

C09CA07

ATC

telmisartan; oral

2.1

65.2

668

2727

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

65.2

488

1748

S06.0

ICD-10 Finland

Concussion

2.0

65.0

766

3295

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

64.9

1021

4839

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.6

64.8

226

528

1DC02, ,

NOMESCO Finland

13.7

64.8

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

124.2

64.8

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

64.8

266

692

ZXD35

NOMESCO Finland

Usual procedure

3.1

64.7

291

800

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.2

64.6

104

122

C10AB02

ATC

bezafibrate; oral

8.3

64.4

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.3

64.4

254

644

M01AX17

ATC

nimesulide; oral

1.6

64.1

1999

11389

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.5

64.0

237

577

D07AC01

ATC

betamethasone; topical

1.5

63.8

3065

19150

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

63.8

714

3014

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.7

63.7

370

1172

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

103.5

63.7

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.9

63.6

325

961

I95.1

ICD-10 Finland

Orthostatic hypotension

3.4

63.6

245

612

P20

ICPC

Memory disturbance

1.8

63.5

1023

4883

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.9

63.5

105

127

3055, ,

Kela drug reimbursment

10.2

63.4

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

18.4

63.3

SPAT1251

SPAT

Organisation of medication

3.8

62.9

204

453

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

10.7

62.6

I49.1

ICD-10 Finland

Atrial premature depolarization

4.0

62.6

187

391

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

8.3

62.3

F05.9

ICD-10 Finland

Delirium, unspecified

5.2

62.3

138

225

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

62.3

896

4125

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

6.6

62.2

108

138

X58

ICD-10 Finland

Exposure to other specified factors

1.7

62.2

1295

6660

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

30.2

62.1

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

11.7

62.0

D82

ICPC

Teeth/gum disease

1.5

62.0

3188

20163

Z49.2

ICD-10 Finland

Other dialysis

10.5

62.0

R5130, ,

SPAT

11.2

62.0

M01AH02

ATC

rofecoxib; oral

1.8

61.9

1032

4976

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.7

61.9

153

275

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.3

61.8

169

330

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.7

61.7

351

1100

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

61.7

1334

6930

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.8

61.6

203

456

PA7BD

NOMESCO Finland

CT angiography of neck and brain

5.6

61.5

125

188

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.9

61.3

118

168

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

6.4

61.3

109

143

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

61.2

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

7.9

61.2

R52.9

ICD-10 Finland

Pain, unspecified

1.9

61.2

806

3603

C10AA02

ATC

lovastatin; oral

3.2

61.1

259

687

C07BB07

ATC

bisoprolol and thiazides; systemic

3.1

61.0

272

744

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.3

61.0

166

323

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

76.6

60.8

RS224, ,

NOMESCO Finland

11.6

60.6

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

6.2

60.6

112

153

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

11.0

60.6

N06AA06

ATC

trimipramine; systemic

4.1

60.3

177

365

5315

FHL

Bypass surgery using a mammary artery

+∞

60.2

QDH05

NOMESCO Finland

Correction of deformity of toe nail

17.7

60.2

J01DA09

ATC

[U] cefadroxil

1.5

60.0

2054

11927

A08AA02

ATC

fenfluramine; oral

7.8

60.0

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

97.8

59.9

RD112, ,

NOMESCO Finland

68.1

59.9

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

75.5

59.8

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.6

59.7

380

1260

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

33.5

59.7

K01

ICPC

Heart pain

7.6

59.7

100

WZC30

NOMESCO Finland

Teaching

1.7

59.7

1342

7040

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

59.3

608

2482

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

59.2

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

59.2

SPAT1307

SPAT

Psychosocial counselling and guidance

3.2

59.1

256

688

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

59.1

446

1603

N17

ICPC

Vertigo/dizziness

1.8

59.0

912

4292

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

5.7

58.9

117

172

IHZ04, ,

SPAT

6.8

58.9

122

J01FA09

ATC

clarithromycin; systemic

1.5

58.8

2563

15656

XF602

NOMESCO Finland

Bloodpressure monitoring

6.0

58.7

112

158

K92.0

ICD-10 Finland

Haematemesis

4.1

58.5

170

348

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

58.5

732

3213

A08AA62

ATC

bupropion and naltrexone; systemic

9.4

58.2

SPAT1244

SPAT

Occupational therapy

6.8

58.2

121

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

58.2

2218

13172

ZX100

NOMESCO Finland

Oral

4.4

58.2

154

293

H36.01

ICD-10 Finland

Diabetic maculopathy

112.3

58.2

Z04.3

ICD-10 Finland

Examination and observation following other accident

3.4

58.1

225

564

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

261.9

58.0

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.8

57.9

188

418

SPAT1139

SPAT

Nutrition survey

3.4

57.8

220

545

A08AA10

ATC

sibutramine; oral

25.7

57.8

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.2

57.7

250

672

N06AA04

ATC

clomipramine; systemic

5.9

57.7

111

158

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.2

57.5

164

331

C10AB05

ATC

fenofibrate; oral

4.5

57.5

150

282

M10.3

ICD-10 Finland

Gout due to impairment of renal function

18.1

57.5

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

19.9

57.4

SPAT1153

SPAT

Removal of sutures

1.5

57.4

2452

14904

I44.0

ICD-10 Finland

Atrioventricular block, first degree

5.8

57.3

113

165

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

+∞

57.3

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

+∞

57.3

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

15.9

57.3

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.5

57.2

384

1307

N05BA02

ATC

chlordiazepoxide; systemic

5.1

57.2

129

214

UJF92

NOMESCO Finland

Capsular endoscopy

4.0

57.2

171

358

PEN23

NOMESCO Finland

Plastic repair of femoral artery

9.1

57.1

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

23.1

57.0

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.6

57.0

350

1140

R06.4

ICD-10 Finland

Hyperventilation

5.3

56.9

122

193

Z94.0

ICD-10 Finland

Kidney transplant status

6.3

56.8

103

138

-45

ICPC

Observ/health educat/advice/diet

3.2

56.7

235

615

N04AA02

ATC

biperiden; systemic

7.7

56.7

G04BD08

ATC

solifenacin; oral

2.2

56.6

526

2064

C02CA01

ATC

prazosin; oral

5.5

56.6

118

182

IHZ05, ,

SPAT

3.6

56.5

201

476

ZX108

NOMESCO Finland

Inhalation

6.6

56.5

125

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

10.3

56.5

E87.2

ICD-10 Finland

Acidosis

21.1

56.4

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

109.0

56.3

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

109.0

56.3

WX144

NOMESCO Finland

Subconjunctival anesthesy

5.5

56.2

116

177

R52.2

ICD-10 Finland

Other chronic pain

3.0

56.2

269

767

K02

ICPC

Pressure/tightness of heart

4.2

56.2

159

319

R01AD12

ATC

fluticasone furoate; nasal

1.5

56.1

2560

15751

N06AX18

ATC

reboxetine; oral

7.4

56.1

100

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3045424) Erythrocytes [Presence] in Urine

1165

2836

3.74

322.26

2.4

1.9

0.08

0.01

estimate

0.70

247

927

(3007853) Bacteria identified in Skin by Aerobe culture

1805

5799

2.94

319.62

2.3

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5266

27740

2.23

318.92

3.1

2.2

76.11

79.75

nmol/l

16.03

4495

25219

(40768797) Stomach Pathology biopsy report

1925

6462

2.83

314.18

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

889

1816

4.38

311.10

2.1

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1761

4819

3.48

307.65

2.4

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1703

3949

4.12

307.65

7.2

4.4

6.01

5.76

kpa

12.62

1654

3872

(3032080) INR in Blood by Coagulation assay

5898

21118

4.23

307.65

21.5

4.0

1.34

1.07

inr

194.48

4947

16554

(3033658) Prothrombin time (PT) actual/Normal

3472

15031

2.41

307.65

7.1

3.5

82.05

94.65

130.86

3421

14757

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2491

1728

15.65

307.65

4.7

5.0

24.92

24.38

mmol/l

12.90

2344

1621

(3021960) Folate [Moles/volume] in Serum or Plasma

3736

14445

2.84

307.65

1.9

1.5

19.63

20.83

nmol/l

4.13

3006

11812

(3027945) Reticulocytes/Erythrocytes in Blood

1886

5413

3.34

307.65

2.8

1.87

1.59

23.43

1657

4864

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2086

5821

3.51

307.65

3.3

2.1

30.47

28.89

22.38

2041

5704

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5199

25407

2.47

307.65

4.1

2.4

160.23

146.39

ug/l

1.77

4726

23790

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

448

179

21.77

307.65

2.1

1.4

1.06

0.85

nmol/l

2.32

355

168

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4194

17087

2.80

307.65

3.4

3.1

37.16

32.83

u/l

1.59

3871

16282

(3024354) Oxygen [Partial pressure] in Venous blood

1381

3357

3.81

307.65

6.1

4.1

5.04

4.64

kpa

6.41

1325

3280

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1011

1711

5.36

307.65

1.9

1.7

1.63

1.52

g/l

2.23

890

1444

(3000991) Gas panel - Venous blood

1667

3892

4.08

307.65

15.2

7.1

—

(3042936) Bacteria identified in Isolate by Culture

2233

7244

3.02

307.65

2.6

1.7

—

(3009343) pH of Capillary blood

3167

2660

14.04

307.65

4.8

4.4

7.42

1.24

2595

2123

(3006315) Basophils [#/volume] in Blood

6165

30310

2.81

307.65

8.6

6.3

0.04

e9/l

0.18

5355

25570

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3556

11511

3.44

307.65

2.9

2.0

3.34

2.64

mg/l

36.52

2979

9687

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

333

202

14.17

307.65

2.1

105.67

70.25

ug/min

0.89

203

105

(3019069) Monocytes/Leukocytes in Blood

6239

27978

3.28

307.65

8.9

6.5

8.84

9.01

4.30

5809

26261

(3003129) Base excess in Capillary blood by calculation

1089

363

27.91

307.65

1.8

2.1

0.43

0.41

mmol/l

0.03

1074

347

(3013115) Eosinophils [#/volume] in Blood

6351

31309

2.89

307.65

9.0

6.4

0.20

0.19

e9/l

3.64

5608

26793

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3409

7726

5.06

307.65

6.1

4.1

29.84

31.67

17.56

2627

4576

(3023368) Bacteria identified in Blood by Culture

4097

13262

3.66

307.65

6.2

3.7

—

(3016502) Oxygen saturation in Arterial blood

1392

3296

3.92

307.65

12.5

6.2

93.86

96.37

28.21

1359

3218

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1312

2505

4.87

307.65

2.0

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2626

6550

4.17

307.65

3.7

2.1

2.34

2.28

g/l

5.54

2416

6043

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2489

7276

3.46

307.65

6.1

2.1

967.05

97.86

ng/l

1.77

2143

5078

(3019225) pH of Specimen

2346

5466

4.36

307.65

4.7

3.6

7.38

7.35

14.14

1691

3690

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1536

2377

6.18

307.65

11.9

7.2

24.77

24.15

mmol/l

7.66

1487

2342

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

955

686

12.71

307.65

4.0

2.7

0.29

0.33

iu/ml

1.36

565

263

(3006504) Eosinophils/Leukocytes in Blood

6233

27906

3.28

307.65

8.8

6.5

2.77

3.01

12.82

5787

26179

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1098

2165

4.62

307.65

2.2

1.5

10.83

4.23

ug/l

8.42

873

1819

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

783

920

7.60

307.65

1.7

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

835

1263

5.92

307.65

3.1

1.9

401.05

443.43

ug/l

0.17

803

1183

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4976

17338

3.77

307.65

4.8

2.0

49.50

19.59

ng/l

5.88

3915

10561

(3019198) Lymphocytes [#/volume] in Blood

6241

30995

2.80

307.65

8.7

6.3

1.93

1.94

e9/l

0.11

5603

26790

(3019309) Folate [Moles/volume] in Red Blood Cells

2680

7164

3.89

307.65

1.9

1.6

789.23

1139.67

nmol/l

91.39

2052

5259

(3052851) Hemolysis interference index of Serum or Plasma

785

1380

5.06

307.65

5.5

2.7

2.13

3.24

index

1.21

441

631

(3024561) Albumin [Mass/volume] in Serum or Plasma

5129

24523

2.52

307.65

6.4

4.6

34.56

36.36

g/l

79.84

4817

22923

(3018010) Neutrophils/Leukocytes in Blood

6304

28248

3.32

307.65

8.6

6.3

59.44

55.53

111.00

5913

26982

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1221

2528

4.44

307.65

7.8

5.3

24.44

24.27

mmol/l

0.83

1204

2515

(3022948) Iron [Moles/volume] in Serum or Plasma

2759

7172

4.04

307.65

3.7

2.1

12.08

17.37

umol/l

1.20

2606

6696

(3013826) Glucose [Moles/volume] in Serum or Plasma

6837

30459

3.75

307.65

7.4

3.4

7.03

6.11

mmol/l

182.26

6514

28820

(3020779) Urea [Moles/volume] in Serum or Plasma

1956

3518

5.51

307.65

11.4

6.4

11.37

8.30

mmol/l

43.36

1843

3390

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2920

7319

4.28

307.65

5.0

3.9

0.82

0.83

mmol/l

5.87

2747

6877

(3022313) Gas panel - Capillary blood

2976

2048

16.80

307.65

4.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1736

3797

4.40

307.65

11.2

5.7

10.66

14.16

kpa

125.04

1656

3687

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1937

5925

3.14

307.65

4.3

5.7

250.59

246.51

u/l

0.45

1825

5685

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2787

2331

13.42

307.65

4.7

4.6

1.32

1.23

mmol/l

0.56

2212

1693

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3200

2715

13.96

307.65

4.8

4.4

5.17

5.03

kpa

14.40

3079

2593

(3012516) Albumin [Mass/volume] in Urine

4667

11715

5.34

307.65

4.3

2.0

66.39

42.22

mg/l

4.69

3182

5819

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2512

6869

3.73

307.65

2.4

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8007

48168

2.92

307.65

10.9

7.4

83.96

79.90

u/l

9.43

7533

45511

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

312

115

23.29

307.65

1.1

57.43

9.62

iu/ml

0.66

(3019977) pH of Arterial blood

1724

3793

4.37

307.65

11.3

5.7

7.41

7.42

1.35

813

1628

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

783

920

7.60

307.65

1.7

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6219

23217

4.25

307.65

2.7

1.7

99.57

97.75

pmol/l

1.84

3633

11542

(3003396) Base excess in Arterial blood by calculation

1725

3783

4.38

307.65

11.3

5.7

0.95

0.46

mmol/l

3.85

1499

3209

(3002032) Base excess in Venous blood by calculation

1717

3879

4.24

307.65

7.2

4.4

1.96

1.81

mmol/l

0.66

1530

3377

(3026782) Osmolality of Urine

3040

10369

3.07

307.65

4.0

2.5

553.35

562.23

mosm/kgh2o

1.22

2750

9054

(3009508) Creatinine [Moles/volume] in Urine

4873

12809

5.23

307.65

4.4

2.1

8.15

8.38

mmol/l

2.26

3745

10726

(3026493) Urate [Moles/volume] in Serum or Plasma

3809

15539

2.68

307.65

3.7

2.3

381.75

331.12

umol/l

126.24

3228

13997

(3027456) Digoxin [Moles/volume] in Serum or Plasma

391

84.68

307.65

3.9

2.5

0.79

0.83

nmol/l

0.12

328

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3957

14022

3.23

307.65

2.6

1.8

199.27

200.48

u/l

0.02

3767

13138

(3022096) Basophils/Leukocytes in Blood

6267

27897

3.33

307.65

8.9

6.5

0.62

0.72

35.89

5827

26135

(3037467) Urinalysis macro (dipstick) panel - Urine

7128

41368

2.51

307.65

6.0

3.7

1.71

2.79

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2588

5810

4.66

307.65

8.9

5.6

1.08

1.03

mmol/l

9.58

2413

5373

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3818

16424

2.51

307.65

3.0

2.4

56.13

68.45

u/l

2.09

3509

15171

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1736

3799

4.39

307.65

11.3

5.7

5.31

5.14

kpa

6.93

1665

3689

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1249

1978

5.87

307.65

3.7

1.7

466.75

83.21

ng/l

50.46

1154

1750

(3020682) Albumin/Creatinine [Ratio] in Urine

4910

11809

5.84

307.65

5.1

2.2

15.00

6.14

mg/mmol

1.86

3210

5751

(3014111) Lactate [Moles/volume] in Serum or Plasma

1509

3816

3.70

307.65

13.4

6.2

1.37

1.21

mmol/l

6.09

1462

3736

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4847

10355

6.62

307.65

4.3

1.8

1893.44

488.01

ng/l

49.95

3902

8318

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2518

6038

4.30

307.65

3.8

2.1

20.45

25.47

54.38

2386

5595

(3013650) Neutrophils [#/volume] in Blood by Automated count

6255

34780

2.33

307.65

11.5

9.7

4.58

3.82

e9/l

100.55

5463

29682

(3044640) Blood type and Crossmatch panel - Blood

4748

19060

3.04

307.65

3.3

2.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3005

10552

2.96

307.65

2.5

1.6

1.31

1.13

mg/l

1.76

2311

8276

(4146454) Self-monitoring of blood glucose

535

48.98

307.65

2.8

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6261

27876

3.33

307.65

11.9

5.7

1.21

1.22

mmol/l

27.05

5693

23769

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6287

29440

3.09

307.65

7.6

6.9

12.38

12.20

umol/l

0.34

5999

28072

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2769

9982

2.81

307.65

4.2

2.8

2.91

2.03

e6/l

3.87

1748

4604

(3001604) Monocytes [#/volume] in Blood

6144

30230

2.79

307.65

8.6

6.3

0.65

0.57

e9/l

91.22

5326

25523

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3818

14475

2.94

307.65

3.1

2.3

—

(3002030) Lymphocytes/Leukocytes in Blood

6290

28818

3.20

307.65

8.8

6.4

25.65

29.30

110.17

5952

27338

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5730

24686

3.18

307.65

10.9

5.3

1.22

mmol/l

9.23

5203

22625

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1425

3557

3.72

307.65

6.0

3.5

108.19

73.59

ng/l

27.08

1271

3118

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1444

1076

12.89

307.65

2.8

3.1

24.77

24.55

mmol/l

1.10

1436

1060

(3012544) pH of Venous blood

1738

3970

4.20

307.65

7.1

4.3

7.37

7.38

1.50

1205

2210

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1209

3115

3.54

307.00

1.8

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7155

43242

2.33

301.96

4.8

2.6

63.01

42.66

u/l

49.50

6719

40645

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

7541

46748

2.39

297.38

5.8

3.8

14.87

10.35

mm/h

96.78

6981

43475

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

816

1648

4.40

289.15

1.9

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6578

38746

2.21

289.09

6.0

3.6

2447.45

1527.57

e6/l

0.28

568

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8722

58222

2.93

287.72

6.8

4.2

1.95

1.92

mu/l

0.89

7954

53130

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1410

4193

3.10

283.49

2.2

2.9

339.51

372.32

nmol/l

7.20

1274

3977

(3020630) Protein [Mass/volume] in Serum or Plasma

1407

4226

3.06

277.78

2.4

3.1

65.90

67.10

g/l

6.03

1264

3907

(3023520) Reticulocytes [#/volume] in Blood

1371

4059

3.10

277.39

2.6

2.9

72.30

64.74

e9/l

8.62

991

2882

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

744

1448

4.54

275.73

1.7

1.5

7.96

12.56

iu/ml

0.51

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1557

4976

2.90

275.36

2.5

2.4

0.21

0.22

g/l

4.86

1444

4725

(3026008) Bacteria identified in Urine by Culture

3247

14724

2.24

274.06

3.7

2.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1456

4501

2.98

273.13

2.5

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7385

46315

2.25

265.23

4.9

3.7

14.83

14.65

pmol/l

7.84

6673

42234

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

825

1801

4.07

263.74

14.7

7.0

15.68

16.44

9.79

818

1755

(3023183) Ammonium ion [Moles/volume] in Plasma

485

665

6.33

262.26

2.6

34.41

36.56

umol/l

0.96

430

591

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1339

4051

3.02

260.12

1.6

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4203

21478

2.09

257.68

5.0

3.0

—

1.15

—

(3019060) Gas panel - Arterial blood

702

1379

4.48

256.85

2.7

2.8

—

(3000034) Microalbumin [Mass/volume] in Urine

290

209

11.87

256.24

3.7

1.9

33.21

22.30

mg/l

0.60

212

125

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1744

6142

2.65

255.10

3.1

3.0

8.07

9.11

umol/l

1.26

1593

5474

(3037121) Protein [Mass/volume] in Urine

835

1908

3.89

250.53

3.6

4.2

794.16

291.52

mg/l

1.09

375

980

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

968

2508

3.45

241.52

16.6

7.4

0.51

0.65

20.84

963

2499

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4937

27252

2.00

239.11

3.4

2.5

—

estimate

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

864

2105

3.65

236.23

5.1

3.5

130.27

130.81

g/l

0.24

836

2063

(3024928) Oxygen saturation in Venous blood

521

854

5.30

234.73

4.7

4.8

64.30

62.35

0.91

496

838

(3002582) Erythrocytes [#/volume] in Urine

3847

19536

2.04

233.99

5.1

3.0

54.34

62.04

e6/l

0.24

3133

14365

(3045414) Leukocytes [Presence] in Urine

1570

5486

2.64

231.56

2.4

1.9

0.00

0.02

estimate

2.33

314

1123

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

431

604

6.17

227.95

2.2

1.8

22.61

28.24

mg/l

1.16

171

212

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

948

2593

3.26

216.38

16.7

7.2

1.27

1.21

0.94

942

2582

(3036489) Thrombin time

670

1460

4.02

213.74

3.2

2.5

21.82

20.59

4.86

635

1306

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

836

2148

3.45

210.40

2.3

2.4

3.81

3.70

g/l

0.72

759

1968

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

836

2150

3.44

210.09

2.3

2.4

4.27

4.17

g/l

2.80

760

1971

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

817

2073

3.49

209.57

1.8

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

836

2155

3.43

209.32

2.3

2.4

7.62

7.12

g/l

11.12

760

1974

(3018095) Leukocytes [#/volume] in Urine

4198

22651

1.94

208.03

6.3

3.5

59.09

77.96

e6/l

1.93

3257

15283

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

591

1209

4.26

204.69

1.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

796

2056

3.42

198.40

2.3

2.4

2.99

2.85

g/l

2.88

717

1875

(3030467) Casts [#/volume] in Urine by Automated count

3335

16877

1.97

196.94

5.0

2.9

0.55

0.34

e6/l

5.36

2614

11728

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

585

1227

4.16

196.04

3.7

3.1

217.94

178.94

15.91

565

1166

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

593

1270

4.07

193.28

3.6

3.1

3.89

3.45

g/l

6.60

565

1218

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

743

1872

3.49

192.23

2.4

2.5

0.73

0.86

g/l

0.33

662

1621

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8771

62007

2.44

187.14

10.7

3.6

42.18

36.41

mmol/mol

307.65

8164

57382

(3007164) IgA [Mass/volume] in Serum or Plasma

2440

11209

2.08

187.14

1.7

1.5

2.62

2.33

g/l

4.90

1464

6924

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1560

5993

2.38

185.30

2.1

1.4

1.53

1.30

26.58

1308

5411

(3038515) Glucose [Moles/volume] in Venous blood

432

744

5.01

183.83

4.4

2.2

7.53

6.39

mmol/l

17.46

427

732

(3022689) Creatine [Moles/volume] in Urine

176

16.02

183.50

1.5

1.3

8.80

10.01

mmol/l

0.64

176

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

713

1821

3.43

180.42

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9077

65448

2.67

180.09

28.9

10.5

24.20

25.87

mg/l

4.98

8339

49789

(3028308) Erythrocytes [#/volume] in Pleural fluid

326

441

6.33

178.07

1.5

1.4

51545.19

52779.95

e6/l

0.02

225

270

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

597

1371

3.79

176.59

3.6

2.8

91.42

94.02

1.66

586

1315

(3024891) Influenza virus A+B Ag [Presence] in Specimen

651

1596

3.56

175.14

1.5

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

138

25.88

174.17

2.3

1.3

151.10

15.50

ug/min

1.56

(3009445) Proteinase 3 Ab [Units/volume] in Serum

762

2086

3.21

172.55

1.6

1.8

16.18

13.98

iu/ml

0.12

(3023199) Leukocytes [#/volume] in Pleural fluid

333

478

5.97

171.71

1.5

1.4

2610.17

3321.56

e6/l

0.23

241

339

(1761482) Bacteria [#/volume] in Urine by Culture

538

1173

3.98

170.89

4.0

3.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2335

10870

2.03

170.52

4.2

2.7

1.03

1.07

e6/l

0.12

1312

5531

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

338

500

5.79

169.11

7.8

5.2

11.08

11.15

mg/l

0.10

305

467

(3005988) Vibrio sp identified in Specimen by Organism specific culture

365

585

5.36

167.99

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

364

584

5.35

167.34

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

363

581

5.36

167.31

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1807

7707

2.16

165.82

1.4

1.3

443.78

529.60

titre

1.39

402

1630

(3024522) Salmonella sp identified in Specimen by Organism specific culture

369

607

5.22

165.10

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

369

618

5.12

161.85

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

365

608

5.15

161.05

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

632

1616

3.41

159.23

2.5

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

466

964

4.17

158.58

1.7

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

332

517

5.50

157.49

1.5

1.4

30.70

39.27

g/l

19.69

264

489

(44816559) Phosphatidylethanol [Mass/volume] in Blood

587

1440

3.54

157.48

1.8

1.4

0.28

0.25

mg/l

0.56

262

691

(3000494) Fungus identified in Specimen by Culture

1706

7253

2.16

157.03

1.8

1.3

—

(3045788) Cell count panel - Pleural fluid

281

374

6.41

155.77

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

484

1068

3.92

151.02

1.7

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1120

4041

2.47

150.71

3.0

2.9

10.37

10.60

g/l

0.86

1036

3752

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

611

1589

3.35

149.76

2.5

2.4

0.04

0.03

g/l

0.21

558

1450

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2043

9484

2.00

147.67

1.6

1.5

407.07

35521778.85

pmol/l

9.11

1641

7922

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

109

32.77

147.47

1.2

1.8

1.49

nmol/l

0.01

(3028026) IgM [Mass/volume] in Serum or Plasma

935

3137

2.64

145.98

2.0

2.1

1.16

1.37

g/l

2.10

837

2904

(3016244) Insulin [Units/volume] in Serum or Plasma

216

233

7.87

143.73

3.1

3.0

40.24

14.91

mu/l

10.05

208

222

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1343

5372

2.25

142.64

3.2

2.3

36.35

59.95

u/l

2.01

1126

4650

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

592

1558

3.30

142.28

2.9

4.1

50.98

37.00

mg/l

1.29

553

1379

(3034860) Kappa light chains.free [Mass/volume] in Serum

593

1564

3.29

142.03

2.9

4.1

70.69

41.17

mg/l

1.96

553

1377

(3051611) Lipemic interference index of Serum or Plasma

310

504

5.25

140.37

5.7

3.0

13.99

14.72

index

0.34

187

266

(3019550) Sodium [Moles/volume] in Serum or Plasma

9220

68462

2.55

139.98

34.3

10.9

139.72

139.92

mmol/l

12.33

9057

66596

(3000330) Specific gravity of Urine by Test strip

826

2686

2.70

136.83

3.8

2.7

1.02

ratio

7.82

715

2438

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

645

1839

3.05

135.71

2.3

2.4

10.45

10.29

g/l

0.34

564

1651

(3023103) Potassium [Moles/volume] in Serum or Plasma

9230

68751

2.52

135.25

35.0

11.0

4.01

3.97

mmol/l

40.29

9051

66720

(3044927) Protein electrophoresis panel - Urine

282

435

5.53

135.03

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

296

486

5.20

132.57

3.7

3.8

—

(40758558) Short blood count panel - Blood

3387

18962

1.74

132.47

9.7

6.4

—

(3004616) Nuclear Ab [Presence] in Serum

358

703

4.36

130.00

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

2469

12724

1.82

127.26

3.5

2.4

5.36

4.76

e6/l

1.51

2235

11520

(3028707) Methadone [Presence] in Urine by Screen method

176

172

8.66

126.45

3.3

2.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

528

1393

3.28

126.17

2.9

4.0

5.82

6.29

ratio

0.05

356

817

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

532

1430

3.22

123.31

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

549

1514

3.14

121.97

5.3

2.7

25.51

25.42

mmol/l

0.25

539

1474

(3005322) IgE [Units/volume] in Serum or Plasma

964

3583

2.37

120.34

1.5

1.3

222.25

260.93

u/ml

0.67

909

3361

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

523

1423

3.17

118.78

2.6

2.5

0.00

g/l

-0.00

478

1354

(36304419) Bacteria [Presence] in Urine

2928

16122

1.72

118.74

5.1

2.8

0.45

1.39

estimate

0.57

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

534

1483

3.11

117.19

2.0

1.7

1.23

2.26

ug/l

1.37

458

1328

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

700

2259

2.70

117.19

2.6

2.0

37.53

41.31

u/l

4.88

596

2089

(3028626) Oxygen [Partial pressure] in Capillary blood

497

1322

3.24

117.09

11.1

5.7

8.35

8.98

kpa

10.76

487

1288

(3000570) Elastase.pancreatic [Mass/mass] in Stool

497

1323

3.24

116.95

1.5

1.3

262.71

276.71

ug/g

0.69

297

753

(3015377) Calcium [Moles/volume] in Serum or Plasma

3589

20940

1.67

116.83

3.4

4.0

2.35

2.36

mmol/l

4.67

2998

19057

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

428

1056

3.48

113.38

4.1

2.4

1.54

1.46

0.57

420

1003

(40768806) Pleura Pathology biopsy report

264

453

4.96

112.53

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

21.71

110.45

15.2

7.8

5.40

4.98

mmol/l

0.44

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

427

1070

3.43

110.45

1.4

1.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

530

1525

3.00

109.37

2.6

2.4

0.00

g/l

-0.00

478

1356

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

8820

65649

2.00

106.83

26.9

10.5

77.32

81.42

ml/min/173m2

57.51

8357

59434

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

228

359

5.39

106.79

3.1

2.2

—

(3021589) Normoblasts [#/volume] in Blood

4533

28525

1.59

105.30

13.4

9.3

0.00

e9/l

0.51

3661

22969

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

169

199

7.18

104.52

1.1

4.33

8.39

u/ml

0.89

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8561

63223

1.88

103.86

6.1

3.5

1.55

1.22

mmol/l

226.55

7808

57965

(3008757) Leukocyte morphology finding [Identifier] in Blood

291

581

4.27

103.38

3.1

3.6

—

(3017732) Neutrophils [#/volume] in Blood

1558

7366

1.90

102.91

3.2

2.9

4.41

4.17

e9/l

1.22

1115

6399

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8664

64299

1.91

102.34

7.5

3.8

6.35

5.55

mmol/l

307.65

7736

58937

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1454

6772

1.92

100.27

1.8

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

480

1374

3.01

99.83

2.8

2.0

13.86

10.89

mg/l

10.63

440

1300

(3051651) Icteric interference index of Serum or Plasma

192

274

5.93

99.46

6.8

3.6

0.68

1.00

index

1.83

186

266

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2326

12539

1.71

98.68

1.3

2.11

2.20

u/ml

0.08

397

3437

(3007930) Methemoglobin/Hemoglobin.total in Blood

374

925

3.46

98.61

4.2

2.4

0.76

0.85

6.11

367

872

(3017143) Hepatitis C virus Ab [Presence] in Serum

1264

5641

1.99

98.58

1.9

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

333

773

3.68

96.43

1.3

1.4

43.58

29.38

u/l

0.75

269

662

(3021440) Promyelocytes/Leukocytes in Blood

1101

4726

2.06

95.44

5.5

4.4

0.04

0.11

4.11

392

1256

(3037756) Immunofixation for Serum or Plasma

381

976

3.34

95.13

1.6

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

148

167

7.48

94.89

2.5

2.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

359

895

3.43

93.49

3.3

3.5

1.55

1.84

0.68

317

804

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4300

27264

1.55

92.49

5.6

5.3

2.37

3.46

ug/l

2.77

3730

25315

(3014271) Vancomycin [Susceptibility]

144

165

7.36

91.15

2.9

2.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

767

2906

2.30

90.74

3.2

3.8

4.36

4.58

pmol/l

6.87

667

2629

(3048689) Calprotectin [Mass/mass] in Stool

1497

7256

1.84

90.51

2.3

2.6

155.00

129.10

ug/g

1.47

1136

5869

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1085

4721

2.03

90.38

3.3

2.2

0.27

0.34

e6/l

0.85

1069

4491

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

335

820

3.49

89.69

1.3

1.2

210.91

329.93

titre

0.63

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

205

344

5.05

89.59

2.1

1.8

374.76

298.06

mu/l

0.92

160

279

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

263

544

4.11

89.24

1.7

1.6

—

(36660697) Celiac disease serology panel - Serum

1016

4342

2.06

88.81

1.2

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

335

826

3.46

88.70

1.3

1.2

111.43

124.76

titre

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

734

2759

2.31

88.39

2.8

2.3

—

(3034770) Mitochondria Ab [Titer] in Serum

434

1257

2.96

88.33

1.2

1.3

1686.25

896.89

titre

—

(3017181) Myelocytes/Leukocytes in Blood

1105

4883

1.99

88.03

5.5

4.4

0.75

0.99

2.16

394

1410

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

245

487

4.27

87.51

1.2

91.71

105.91

u/ml

—

(3022621) pH of Urine by Test strip

1066

4660

2.01

87.51

2.6

2.1

5.95

6.06

3.20

559

3078

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

221

410

4.57

85.97

1.2

1.3

134.55

181.69

titre

0.42

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

473

1458

2.79

85.96

1.7

1.6

0.25

0.23

g/l

4.12

440

1393

(3014051) Protein [Presence] in Urine by Test strip

2984

17643

1.58

85.59

3.6

2.5

0.05

0.03

0.26

123

343

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

272

596

3.88

85.41

1.2

72.09

30.84

u/ml

0.93

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

220

410

4.55

85.12

1.2

1.3

60.00

70.00

titre

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

208

370

4.76

85.05

6.8

3.7

352.40

371.50

umol/l

0.84

182

301

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

531

1750

2.61

84.77

7.3

3.3

45.92

47.54

0.69

521

1722

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

244

496

4.17

84.68

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

479

1505

2.73

83.94

1.7

1.5

1.25

1.16

g/l

6.24

449

1446

(3022145) Colonoscopy Study observation

1514

7541

1.79

83.13

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

205

368

4.72

82.94

1.3

7.04

5.09

mmol/l

10.19

186

337

(3007566) Smooth muscle Ab [Titer] in Serum

431

1288

2.87

82.90

1.2

1.3

66.15

210.42

titre

1.89

118

(3002179) Metamyelocytes/Leukocytes in Blood

1050

4654

1.98

82.66

4.7

4.3

0.73

0.71

0.09

427

1353

(3023420) DNA double strand Ab [Units/volume] in Serum

625

2257

2.39

82.26

1.7

9.33

7.94

iu/ml

0.32

118

515

(4015189) Microbial culture of sputum

104

9.82

82.16

2.5

2.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

201

361

4.71

81.27

1.3

901.61

649.94

u/l

0.30

189

345

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

144

189

6.42

80.84

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

144

189

6.42

80.84

1.5

—

(3049717) Cytology report of Urine Cyto stain

608

2186

2.40

80.78

2.5

2.9

—

(3017354) Segmented neutrophils/Leukocytes in Blood

264

593

3.78

80.08

3.2

3.7

59.41

54.79

2.42

232

507

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

199

363

4.64

79.00

2.0

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

442

1380

2.74

78.34

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

235

494

4.03

78.05

1.9

2.8

1.22

1.02

g/24h

0.55

143

302

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2022

11081

1.65

78.01

1.4

1.3

40.20

41.61

iu/ml

0.09

504

3544

(46235355) HIV 1 and 2 tests - Meaningful Use set

1553

7949

1.74

77.13

1.9

1.7

—

(3025159) Blasts/Leukocytes in Blood

1051

4801

1.92

75.43

5.6

4.6

0.13

0.49

1.61

360

1205

(3024666) Lithium [Moles/volume] in Serum or Plasma

13.35

74.37

13.7

8.6

0.59

0.57

mmol/l

0.15

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

529

1856

2.45

74.02

7.0

5.3

1.75

1.24

mg/l

27.47

491

1726

(3018851) Theophylline [Moles/volume] in Serum or Plasma

28.08

73.74

2.8

1.4

48.88

39.82

umol/l

0.77

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

314

842

3.17

72.78

1.9

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1879

10308

1.64

71.42

1.3

18.82

13.85

u/ml

0.64

489

4170

(3000093) Morphology [Interpretation] in Blood Narrative

215

452

4.03

71.41

1.1

—

(4195642) Thrombophilia screening test

237

540

3.72

70.46

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

362

1076

2.87

70.24

9.4

4.4

948.19

2658.12

iu/ml

0.41

115

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

368

1104

2.84

70.21

2.0

1.5

—

(3042733) HLA Ab [Presence] in Serum

8.76

70.00

5.3

4.1

—

(4198724) Urine methamphetamine measurement

14.17

69.88

2.5

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

531

1922

2.37

69.33

1.6

1.7

16.81

17.19

u/ml

0.04

562

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

469

1614

2.49

68.32

1.3

1.2

2.49

6.81

u/ml

0.67

155

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

467

1612

2.48

67.59

1.3

6.09

6.06

u/ml

0.00

248

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

241

572

3.57

67.54

1.3

1.4

23.76

34.58

u/l

4.73

189

469

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

353

1061

2.84

67.11

1.9

1.5

—

(40761536) Microorganisms panel - Urine sediment

133

4409

0.24

66.92

4.7

3.2

—

(3038026) Centromere Ab [Units/volume] in Serum

196

405

4.09

66.61

1.2

12.36

47.73

u/ml

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6207

58720

0.68

66.41

35.4

13.1

330.02

333.38

g/l

105.25

6166

58380

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

301

833

3.07

66.18

5.2

3.2

521.77

16834.68

u/ml

0.83

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

237

568

3.53

65.47

1.4

1.2

5.42

3.95

u/ml

0.87

109

283

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

8.59

64.66

1.9

1.2

129.48

69.42

umol/l

0.72

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

481

1721

2.39

64.38

1.3

1.2

72.48

43.65

u/ml

0.55

107

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

408

1355

2.57

63.95

1.2

1.85

4.56

u/ml

0.69

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1050

5046

1.82

63.77

1.6

1.5

—

5.89

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

145

243

5.03

63.51

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

434

1490

2.49

63.50

1.6

18111.12

12268.15

e6/l

1.17

323

1046

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

13.49

63.30

1.4

1.2

205.54

80.68

ng/l

1.25

(3005570) Glucose [Moles/volume] in Urine

203

448

3.83

63.14

1.7

—

14.20

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

146

249

4.94

62.70

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

124

185

5.64

61.49

1.3

1.1

—

(3003181) Sodium [Moles/volume] in Urine

267

719

3.15

61.45

1.6

65.71

66.45

mmol/l

0.08

213

566

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

197

435

3.83

61.23

1.2

1.5

—

titre

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

435

1538

2.42

59.73

1.5

1.4

—

(3023419) Bacteria identified in Sputum by Culture

215

518

3.51

58.95

3.1

2.4

—

(3051101) Glucose [Moles/volume] in Cord blood

23.62

58.69

3.2

1.5

8.29

6.05

mmol/l

4.49

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

219

536

3.46

58.64

1.2

1.1

116.20

117.94

0.24

210

468

(3006184) Hemoglobin [Mass/volume] in Capillary blood

308

925

2.83

58.62

1.9

1.7

136.73

132.67

g/l

1.40

175

664

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

248

661

3.18

58.06

1.1

1.53

1.46

g/l

1.71

214

622

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

156

301

4.37

57.90

1.2

1.3

14.68

18.76

u/l

0.64

146

292

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

9.54

57.44

1.2

1.3

255.63

323.52

pmol/l

0.51

(3021879) Hepatitis B virus core Ab [Presence] in Serum

875

4103

1.85

57.24

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

433

1558

2.37

57.18

1.4

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

293

871

2.86

56.82

1.5

1.6

0.70

0.92

g/l

2.79

259

706

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

276

795

2.94

56.63

1.2

5.64

9.24

u/ml

0.32

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

160

321

4.20

56.54

1.0

1.1

282.88

285.53

mg/l

0.17

137

310

(3009214) Lutropin [Units/volume] in Serum or Plasma

419

1496

2.39

56.28

1.4

1.5

8.22

9.46

u/l

1.16

323

1157

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

125

206

5.10

55.81

1.8

2.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

26.29

55.70

10.9

8.2

69.54

37.50

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

226

584

3.27

55.63

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

9.78

55.25

1.2

1.4

61.53

55.64

mu/l

0.10

(3026250) Tacrolimus [Mass/volume] in Blood

105

150

5.88

54.41

45.9

38.4

6.92

6.85

ug/l

0.13

131

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

122

202

5.08

54.19

1.8

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

122

202

5.08

54.19

1.8

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

229

607

3.19

54.11

1.2

1.3

0.11

0.22

nmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

223

593

3.18

52.42

1.2

1.3

0.57

2.52

nmol/l

0.51

208

576

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

107

163

5.52

51.97

2.3

3.0

0.62

mmol/l

0.04

107

163

(3020491) Glucose [Moles/volume] in Blood

149

305

4.11

51.33

1.5

1.3

8.24

6.09

mmol/l

4.43

219

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

325

1079

2.56

50.94

1.8

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

205

533

3.25

49.99

1.2

1.3

54.74

71.51

u/l

2.38

190

467

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

137

270

4.27

49.56

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

137

270

4.27

49.56

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

137

270

4.27

49.56

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

216

584

3.13

49.42

1.4

1.2

4.15

4.82

u/ml

0.17

228

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

137

271

4.25

49.33

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

228

642

3.00

48.70

1.2

7.66

6.51

mmol/l

6.13

185

549

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

225

630

3.02

48.53

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

104

165

5.29

48.42

11.3

1.4

59.49

2356.10

mg/l

0.77

118

(3010375) cycloSPORINE [Mass/volume] in Blood

112

191

4.93

48.17

39.3

28.6

125.76

117.08

ug/l

0.53

166

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

192

495

3.27

47.47

1.2

1.3

—

nmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8668

67168

1.56

47.39

7.2

4.1

1.29

1.54

mmol/l

307.65

7957

62145

(21494755) Public health laboratory ask at order entry panel

556

8384

0.53

46.59

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

116

210

4.64

46.58

1.7

1.8

40.14

41.04

g/l

0.60

116

210

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8803

68512

1.58

46.44

7.7

4.6

2.53

3.03

mmol/l

307.65

8068

63399

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

163

390

3.52

45.22

1.3

1.2

2.09

2.02

mmol/l

0.30

153

377

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

564

2480

1.95

44.59

2.3

1.4

4.59

3.41

mg/l

1.85

511

1638

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9216

72661

1.71

44.56

17.9

9.4

30.97

25.77

u/l

30.53

8933

70146

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8697

67617

1.54

44.55

7.1

4.2

4.38

5.01

mmol/l

307.65

8125

62896

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

312

1090

2.43

43.94

1.8

1.4

20.05

10.91

u/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

155

5.20

43.89

1.9

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

162

394

3.46

43.87

2.5

3.1

261.73

248.27

e6/l

0.26

143

315

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

192

523

3.10

43.42

1.2

1.3

0.18

nmol/l

0.57

139

438

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

209

601

2.94

43.07

2.0

1.3

—

(3025941) Bacteria identified in Stool by Culture

636

2947

1.85

42.86

1.3

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

4609

32415

1.34

42.77

4.0

3.1

21.81

2.87

estimate

2.36

707

6211

(44790048) Parainfluenza type 2 nucleic acid detection

185

500

3.12

42.40

2.1

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

185

500

3.12

42.40

2.1

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

185

500

3.12

42.40

2.1

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

185

501

3.11

42.26

2.1

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

238

744

2.70

42.06

1.6

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

4564

32120

1.34

41.79

4.0

3.1

0.00

estimate

0.80

674

6071

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5431

39218

1.34

41.64

3.0

2.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9281

73477

1.72

41.62

36.0

13.2

88.24

75.62

umol/l

101.15

9148

72403

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

142

5.26

41.23

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

172

453

3.20

41.14

1.7

2.6

—

(3009261) Glucose [Presence] in Urine by Test strip

4641

32805

1.33

40.90

4.1

3.1

1.05

0.01

estimate

0.86

604

6199

(3013139) Helicobacter pylori Ag [Presence] in Stool

765

3811

1.73

40.35

1.2

—

(3011985) Renin [Units/volume] in Plasma

213

643

2.80

40.22

1.3

1.6

115.07

64.85

mu/l

0.93

186

583

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

901

4701

1.66

39.99

2.5

2.4

18.13

21.99

au/ml

0.71

632

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

138

321

3.62

39.95

3.0

1.6

—

(40768446) Kidney Pathology biopsy report

180

4.62

39.60

2.1

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

154

4.96

39.53

1.9

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

7.61

39.36

1.7

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

142

5.14

39.34

1.6

1.1

1.44

0.95

promille

2.11

110

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

153

386

3.34

39.20

2.5

3.0

591.32

542.39

e6/l

0.30

133

296

(3010838) Calcium [Moles/time] in 24 hour Urine

280

988

2.40

38.61

2.1

1.9

5.10

5.51

mmol/24h

1.20

246

893

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

132

306

3.63

38.42

1.2

1.3

40.11

22.16

u/l

1.85

116

252

(40762887) Creatinine [Moles/volume] in Blood

16.71

38.33

1.6

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

134

315

3.58

38.22

1.2

1.3

114.35

77.22

u/l

2.56

121

268

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4045

28223

1.32

38.03

2.0

1.7

1.58

1.29

mmol/l

47.71

3209

23800

(3006462) Nitrate [Presence] in Urine

104

205

4.26

37.70

3.9

2.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

887

2.46

37.64

1.6

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

111

231

4.04

37.51

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

159

429

3.12

36.59

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

136

333

3.43

36.52

1.3

28.57

577.65

titre

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

479

2132

1.91

36.46

2.1

1.7

201.41

220.11

pmol/l

3.78

444

2065

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

194

588

2.78

36.39

1.3

1.5

280.92

347.90

pmol/l

0.71

166

512

(3018418) pH of Serum or Plasma

2518

16457

1.37

36.26

7.2

3.9

7.39

7.40

5.03

1886

11174

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

585

2780

1.80

36.23

2.1

1.8

34.75

42.75

nmol/l

18.99

561

2741

(3048929) Epstein Barr virus Ab [Presence] in Serum

381

1568

2.06

36.20

1.5

1.3

—

(4062490) Immunoglobulin typing, IgG

175

505

2.92

35.90

1.5

1.3

—

(3015736) pH of Urine

3655

25288

1.32

35.79

3.5

2.8

6.05

6.18

8.81

1895

14167

(3011288) Drugs identified in Urine by Screen method Nominal

207

655

2.67

35.78

3.7

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2717

18016

1.35

35.51

3.5

3.1

0.79

0.78

ug/l

0.05

1753

10964

(1761868) Lipid panel - Serum or Plasma

2933

29708

0.75

35.41

3.8

2.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

283

3.59

34.80

1.2

1.1

—

(4211845) Urine protein measurement

106

226

3.94

34.71

3.9

2.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

125

300

3.50

34.61

1.7

1.8

15.27

28.31

umol/l

6.42

115

282

(3004775) Volume in Urine collected for unspecified duration

6.38

34.39

2.3

2.2

683.20

702.88

0.11

(3017569) Oxygen content in Arterial blood

122

5.15

34.08

1.8

2.5

16.36

15.87

0.47

122

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1330

7845

1.48

34.00

3.0

2.1

12.35

14.67

nmol/l

24.20

1160

7349

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

145

395

3.09

32.88

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

145

395

3.09

32.88

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

145

395

3.09

32.88

1.8

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

335

1362

2.08

32.88

1.1

5.24

6.69

eliau/ml

0.31

237

(3028192) IgG subclass 2 [Mass/volume] in Serum

172

518

2.80

32.69

1.4

1.3

2.53

3.10

g/l

3.49

156

385

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

200

654

2.58

32.42

1.5

2.4

626.67

2420.00

titre

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

808

4320

1.61

32.28

1.4

1.3

55.04

62.29

au/ml

0.34

353

(3024139) IgG subclass 3 [Mass/volume] in Serum

171

518

2.78

32.16

1.4

1.3

0.33

0.43

g/l

1.98

153

386

(3027135) IgG subclass 1 [Mass/volume] in Serum

171

518

2.78

32.16

1.4

1.3

6.96

6.93

g/l

0.03

149

387

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

170

517

2.77

31.74

2.4

23.72

29.65

iu/ml

0.28

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

184

584

2.65

31.66

1.1

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

136

365

3.13

31.63

1.3

1.6

30.20

21.12

u/ml

0.41

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

176

4.19

31.38

2.5

1.3

4464.80

1285.25

u/ml

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.18

31.30

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

165

499

2.78

31.14

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

654

8533

0.61

31.07

1.4

—

(3033099) Centromere Ab [Titer] in Serum

130

4.77

30.88

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.88

30.79

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

7.30

30.48

1.3

1.1

—

(3035880) pH of Pleural fluid

184

4.06

30.41

1.2

7.35

7.36

0.09

124

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

291

1157

2.13

30.29

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.59

30.22

2.0

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

151

443

2.87

30.14

1.4

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

261

996

2.21

30.09

1.9

1.4

149.98

141.50

au/ml

0.57

367

(3035320) C reactive protein [Mass/volume] in Body fluid

155

462

2.82

30.06

2.6

2.2

33.39

32.90

mg/l

0.04

122

322

(40768443) Skin Pathology biopsy report

604

3055

1.69

29.96

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

384

1695

1.92

29.96

1.2

1.1

3.78

3.62

0.11

281

(1001926) Buprenorphine [Presence] in Urine by Screen method

251

945

2.24

29.90

2.6

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

7.40

29.54

1.1

—

(3028433) Virus identified in Specimen by Culture

168

4.09

28.38

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

132

372

2.98

28.31

1.2

1.1

343.31

378.12

nmol/l

0.96

104

332

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

126

347

3.05

28.12

1.4

1.5

13.82

11.78

umol/l

2.51

121

334

(4034850) Laboratory test

1834

0.25

27.64

4.0

6.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

179

3.93

27.61

1.2

1.4

192.93

159.63

mmol/24h

1.47

179

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.96

27.53

2.0

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.47

27.47

2.8

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

180

3.91

27.40

2.3

3.7

1.97

1.75

ratio

0.36

161

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

6.75

27.33

1.4

1.5

7.77

491675.23

nmol/l

1.30

(3035947) Staphylolysin Ab [Units/volume] in Serum

231

3.52

27.26

1.2

1.1

3.67

3.00

iu/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

196

692

2.39

27.09

1.2

1.1

—

(4268621) Lupus anticoagulant assay

138

409

2.84

27.09

2.5

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

135

4.40

27.01

1.4

2.0

8.57

6.81

mmol/l

3.86

135

(3026051) Granulocytes/Leukocytes in Pleural fluid

6.21

26.98

1.3

19.00

22.72

0.33

(3016038) Potassium [Moles/volume] in Urine

107

275

3.26

26.76

1.4

1.5

34.82

37.96

mmol/l

0.58

240

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

107

277

3.24

26.46

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

107

277

3.24

26.46

1.5

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.81

26.36

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1823

11830

1.35

26.20

3.2

3.4

2.47

2.45

mmol/l

7.26

1482

10751

(1616796) Gas panel - Central venous blood

196

705

2.34

26.01

4.4

2.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

254

1021

2.10

25.75

1.5

1.3

269.91

250.15

u/ml

0.51

162

627

(4035726) Immunohistochemistry procedure

1100

6583

1.44

25.62

1.5

1.4

—

(3011412) CD3 cells [#/volume] in Blood

164

548

2.52

25.53

2.5

2.7

1433.69

1197.67

e6/l

1.73

145

471

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

+∞

25.23

1.2

0.0

95.38

—

ug/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

7.41

25.10

1.9

3.0

16.37

20.02

umol/l

0.78

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2087

0.33

24.93

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1106

6658

1.43

24.91

5.0

4.3

—

(3002619) Bacteria identified in Specimen by Culture

142

4.13

24.58

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

257

3.23

24.41

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

148

481

2.59

24.40

2.4

2.7

0.79

0.67

e9/l

1.46

142

469

(3024932) HLA-DR beta [Type]

137

4.16

24.10

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

172

610

2.37

23.60

2.6

2.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

658

3609

1.55

23.41

1.2

127.09

162.78

u/ml

1.43

195

1354

(3040151) Glucose [Moles/volume] in Capillary blood

112

325

2.89

22.91

3.9

2.5

8.19

6.28

mmol/l

5.14

274

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.65

22.91

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

579

3109

1.58

22.58

1.1

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1121

6881

1.40

22.49

3.3

5.0

20.86

26.63

ug/l

0.26

927

5549

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

191

3.51

22.47

2.6

2.5

53.68

51.62

umol/l

0.17

177

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

309

1400

1.86

22.33

1.5

655.49

529.51

mg/l

0.74

289

1352

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.95

22.31

1.8

1.5

0.45

1.35

mg/l

1.90

(3038071) Oxygen [Partial pressure] in Mixed venous blood

8.95

22.31

5.2

13.6

7.93

6.17

kpa

1.18

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.95

22.31

1.8

1.5

1.55

1.48

mg/l

0.03

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.95

22.31

1.8

1.5

0.71

1.01

mg/l

0.31

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.95

22.31

1.8

1.5

2.64

3.45

mg/l

0.25

(40757373) Influenza virus identified in Isolate

6.12

22.31

2.2

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

147

502

2.46

21.92

1.4

143807.57

83035.89

e6/l

0.44

102

347

(3008295) Osmolality of Serum or Plasma

129

414

2.62

21.86

1.6

1.3

281.34

278.46

mosm/kgh2o

0.50

330

(3024471) HLA-A [Type]

144

3.89

21.84

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

102

290

2.95

21.65

1.5

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

286

1277

1.89

21.63

3.9

2.5

24.72

28.90

mg/l

1.20

187

821

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

160

572

2.35

21.60

2.1

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

127

4.08

21.55

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

8.09

21.41

3.4

1.4

—

(3034426) Prothrombin time (PT)

104

4.42

21.14

1.4

1.1

29.11

27.09

1.18

104

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

122

4.11

21.06

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

384

1891

1.72

21.01

1.6

1.5

0.05

1.31

iu/ml

0.63

328

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

127

4.02

20.77

1.2

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

581

7155

0.66

20.72

1.7

3.46

3.67

mmol/l

3.71

420

5029

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

143

3.80

20.55

2.2

1.4

16538.22

18715.87

e6/l

0.07

(3017704) Immunofixation for Urine

195

3.35

20.47

1.4

1.9

—

(3016879) Cocaine [Presence] in Urine

291

1331

1.85

20.44

2.6

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.66

20.34

1.1

—

(3002256) Pathology report gross observation

1476

9616

1.33

20.12

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1269

13590

0.75

20.07

4.8

4.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

116

4.11

20.00

1.3

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

146

519

2.36

20.00

3.0

3.3

18.54

17.94

nmol/l

0.28

131

505

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

102

4.35

19.95

1.2

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.35

19.57

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

161

3.53

19.39

2.4

1.4

15081.22

4754.51

e6/l

0.39

101

(4024509) Urine culture

461

2432

1.61

19.36

1.9

1.7

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6301

56279

0.82

19.31

38.6

13.0

14.17

13.44

241.11

6228

55288

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

214

903

1.99

19.13

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.57

19.01

1.3

1.30

1.64

iu/ml

0.49

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

205

3218

0.52

19.00

1.1

0.70

0.64

ratio

0.64

447

(3014891) Appearance of Pleural fluid

7.16

18.79

1.7

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

6.17

18.69

1.7

3.1

1.32

1.61

mmol/l

0.28

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

222

3374

0.54

18.49

1.1

1.42

1.52

g/l

7.00

222

3374

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

3.90

18.39

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

3.74

18.26

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

305

1467

1.75

18.17

1.1

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

168

664

2.13

17.92

1.7

1.6

58.66

55.61

0.41

116

403

(40762814) Titanium [Mass/volume] in Blood

104

4.10

17.88

2.5

2.6

4.56

3.67

ug/l

0.24

(3044290) Cell count panel - Cerebral spinal fluid

255

1171

1.83

17.73

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.35

17.68

1.4

1.3

0.27

0.47

iu/ml

0.71

(3001556) Androgen free Index in Serum or Plasma

20.49

17.64

2.0

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

400

2094

1.62

17.36

1.8

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

149

3.48

17.33

1.6

1.7

0.34

0.37

ug/l

0.15

111

(3000764) Benzodiazepines [Presence] in Urine

300

1461

1.73

17.14

2.6

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

159

3.37

17.02

1.0

4.61

8.33

u/ml

0.80

108

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

875

9676

0.73

16.87

2.1

2.0

3.88

3.59

ratio

8.71

726

7677

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

261

1228

1.79

16.79

1.5

3.91

3.48

mmol/l

7.92

245

1186

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

301

2.64

16.62

1.1

2.58

12.13

nmol/l

0.92

(3024263) Appearance of Synovial fluid

283

2.69

16.51

2.5

1.8

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

111

3.84

16.43

1.4

1.6

79.14

216.89

nmol/24h

0.81

111

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

100

4.01

16.39

1.2

15.38

12.72

pmol/l

0.15

(3047189) Immunofixation for 24 hour Urine

253

2.78

16.19

1.8

2.2

—

(3028300) Cannabinoids [Presence] in Urine

301

1494

1.70

16.08

2.6

1.4

—

(3027008) Opiates [Presence] in Urine

300

1489

1.70

16.03

2.5

1.4

—

(3004451) EKG impression Narrative

4.28

15.95

1.3

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

15.03

15.91

1.3

1.0

43.11

41.06

mg/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

114

3.74

15.85

1.9

2.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

209

935

1.88

15.82

1.7

1.5

—

(3026480) Teichoate Ab [Titer] in Serum

6.78

15.57

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

137

3.42

15.29

1.1

—

(3045142) Bone marrow Pathology biopsy report

186

810

1.93

15.28

1.3

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

266

2.68

15.27

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

286

2.61

15.18

1.2

1.4

5.23

5.56

u/l

0.41

248

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

337

2.46

15.02

1.1

—

0.62

—

(3036670) Protein [Mass/volume] in Synovial fluid

177

3.07

14.98

1.3

1.2

39.81

39.98

g/l

0.02

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

127

3.49

14.93

1.3

313.55

246.10

ug/l

0.14

(21494434) Karyotype in Bone marrow

139

551

2.12

14.80

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

285

1436

1.67

14.43

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

108

391

2.31

14.33

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.33

14.31

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.83

14.17

1.1

1.2

0.70

0.65

umol/24h

0.16

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

111

409

2.27

14.15

1.5

1.3

2.63

4.97

u/ml

0.95

253

(3023410) Appearance of Cerebral spinal fluid

151

630

2.01

14.06

1.8

2.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.79

13.98

1.5

1.1

18.73

13.49

g/l

3.05

(42529406) Shigella sp [Presence] in Stool by Culture

285

1451

1.65

13.88

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

210

982

1.80

13.87

1.1

1.39

3.35

2.37

172

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

136

552

2.07

13.65

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

278

1416

1.65

13.53

1.7

2.0

3.21

4.26

iu/l

1.89

581

(3007461) Platelets [#/volume] in Blood

9327

75784

1.37

13.37

41.2

15.7

248.71

250.61

e9/l

1.91

9187

73495

(3000060) B lymphocytes [#/volume] in Blood

195

2.83

13.25

3.3

2.6

0.25

0.31

e9/l

0.50

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.97

13.22

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

274

2.50

12.99

1.1

1.2

17.50

16.69

u/l

0.11

243

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

136

564

2.02

12.91

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

164

726

1.90

12.91

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

275

2.50

12.90

1.1

1.2

83.65

75.78

u/l

0.60

246

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.63

12.88

1.6

1.1

31.64

26.28

g/l

1.24

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

102

378

2.26

12.87

1.1

—

(3035941) MCH [Entitic mass]

9327

75829

1.36

12.83

41.0

15.6

30.17

30.41

29.31

9237

74738

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

278

1436

1.63

12.83

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

9328

75843

1.36

12.78

42.7

15.9

40.09

41.96

14.56

9237

74701

(3024731) MCV [Entitic mean volume] in Red Blood Cells

9327

75838

1.36

12.73

41.1

15.7

91.03

91.00

0.25

9239

74747

(3010813) Leukocytes [#/volume] in Blood

9330

75867

1.36

12.72

41.3

15.7

7.35

6.35

e9/l

184.40

9139

73236

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.65

12.72

1.8

1.3

1566.67

1102137.50

u/ml

—

(3010503) CD19 cells [#/volume] in Blood

355

2.29

12.61

2.2

2.8

167.65

449.30

e6/l

0.75

350

(3026361) Erythrocytes [#/volume] in Blood

9327

75848

1.36

12.61

41.2

15.7

4.50

4.57

e12/l

24.81

9136

73229

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.06

12.58

1.3

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.96

12.51

1.5

1.2

71.33

75.20

0.12

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

103

389

2.22

12.44

1.6

1.3

83.94

77.73

0.49

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

13.11

12.42

1.3

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

232

2.60

12.30

2.6

4.0

1.39

1.40

ug/l

0.01

227

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

108

418

2.16

12.30

1.2

62.54

47.55

mg/l

0.39

100

354

(3000963) Hemoglobin [Mass/volume] in Blood

9327

75876

1.35

12.29

41.4

15.8

134.76

138.21

g/l

74.79

9239

74788

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

251

1283

1.65

12.10

1.2

53.98

45.75

u/ml

0.26

120

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

153

2.95

11.72

1.1

1.2

106.04

110.78

0.50

143

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

12.52

11.66

4.9

3.7

—

(3044007) Cell count panel - Peritoneal fluid

146

2.98

11.47

2.6

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

204

1005

1.70

11.33

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

109

444

2.06

10.94

1.3

1.1

95.72

116.86

pmol/l

4.31

109

444

(21494815) CD4 cells/Lymphocytes in Specimen

140

623

1.88

10.92

2.4

39.86

36.84

1.38

131

618

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

174

2.74

10.85

1.1

1.2

0.32

0.30

g/l

1.53

146

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

13.21

10.84

1.1

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.70

10.83

1.5

1.3

81.94

85.38

0.11

(3027944) Amphetamines [Presence] in Urine

275

1482

1.56

10.70

2.5

1.3

—

(3035715) Granulocytes [#/volume] in Blood

1012

0.38

10.65

3.7

3.3

4.75

3.75

e9/l

2.63

1012

(3050794) Legionella sp Ab [Presence] in Serum

4.52

10.40

1.2

—

(3000285) Sodium [Moles/volume] in Blood

3.76

10.15

1.6

1.2

139.38

139.19

mmol/l

0.11

(3041096) Erythrocytes [Presence] in Urine by Automated

2362

17324

1.18

10.13

3.8

2.7

1.77

0.32

estimate

0.85

371

4810

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

153

718

1.79

10.11

1.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

839

0.34

10.08

2.8

2.1

13.35

13.14

0.68

823

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

140

2.86

9.96

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

178

2.63

9.91

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.76

9.88

1.6

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

176

866

1.70

9.88

3.3

2.9

1149.49

358.15

u/ml

0.36

176

856

(3024869) Neuronal Ab [Presence] in Serum

3.38

9.79

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

297

2.22

9.75

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

161

2.70

9.68

1.7

2.25

3.50

nmol/l

0.47

133

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.66

9.66

1.1

1.0

0.03

u/ml

0.06

(3020393) Adenovirus Ag [Presence] in Stool

116

3.02

9.59

2.3

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

120

532

1.89

9.53

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.96

9.53

1.3

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

239

2.34

9.35

1.2

1.3

11.94

6.71

mmol/l

9.01

233

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

11.82

9.33

1.2

1.1

284.00

119.83

pmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

251

1376

1.53

9.11

2.9

3.9

175.46

407.72

u/ml

1.48

228

1249

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

10.91

9.01

1.0

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

193

2.47

8.92

1.6

3.99

3.59

umol/l

0.37

169

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

8.34

8.77

1.1

1.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

422

4725

0.73

8.68

4.2

2.3

56.36

71.88

ml/min/173m2

11.93

208

1755

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

307

2.12

8.65

2.1

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

125

580

1.80

8.65

1.1

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

836

0.39

8.60

1.3

1.6

956.26

1075.61

mu/l

0.19

689

(3035933) Granulocytes/Leukocytes in Blood

1360

0.52

8.57

2.7

3.0

59.00

56.76

0.94

1360

(3028679) Herpes simplex virus Ab [Presence] in Serum

287

2.16

8.52

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

238

1311

1.52

8.48

1.5

1.8

299.27

253.20

mu/l

1.76

227

1227

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

110

495

1.86

8.40

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

265

1497

1.49

8.38

1.2

1.1

1.67

1.90

u/ml

0.14

149

872

(40759836) Histone Ab [Presence] in Serum by Immunoblot

109

492

1.85

8.26

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

393

1.96

8.21

2.8

2.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

337

2.03

8.15

1.1

—

1.01

—

(3033086) Enterovirus Ab [Titer] in Serum

15.48

8.04

1.0

1.1

—

(3022670) pH of Venous cord blood

4.51

8.01

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

159

808

1.65

8.00

2.1

2.3

1213.17

4912.51

u/l

1.63

304

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

102

1512

0.56

7.98

1.2

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

140

2.62

7.85

1.0

1.4

128.06

139.17

nmol/l

0.19

(40768441) Liver Pathology biopsy report

105

478

1.84

7.77

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

101

455

1.86

7.73

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

351

1.98

7.66

2.0

3.4

7.59

15.23

umol/l

1.71

270

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.16

7.65

1.2

1.5

—

(3018133) Calcium [Moles/volume] in Urine

167

2.45

7.62

3.7

2.9

2.53

2.71

mmol/l

0.25

155

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1428

10276

1.18

7.47

1.6

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

115

2.76

7.46

1.3

1.2

80.60

88.74

0.59

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

280

0.18

7.35

1.7

1.5

51.22

62.42

ug/l

—

280

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

101

463

1.83

7.34

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

147

2.50

7.15

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

9.73

7.14

6.7

14.8

81.56

297.00

e6/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

108

510

1.77

7.13

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

279

1647

1.42

7.08

1.2

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.42

7.05

1.3

1.1

285.22

402.21

umol/24h

1.16

(3019174) dRVVT (LA screen)

6.25

7.02

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

162

857

1.58

6.99

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

229

1311

1.47

6.86

1.1

3.38

3.96

u/ml

0.36

121

771

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

165

881

1.57

6.85

1.1

5.76

3.80

eliau/ml

0.49

462

(3042517) Benzodiazepines panel - Urine

15.28

6.85

3.1

2.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

377

4132

0.75

6.76

4.5

3.5

1.23

1.24

mmol/l

0.35

357

3453

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.68

6.75

1.4

1.2

68.50

91.45

2.13

(3042111) Morphology [Interpretation] in Bone marrow Narrative

176

960

1.54

6.66

1.6

1.8

—

(44806071) Cardiolipin IgM antibody measurement

4.17

6.59

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

468

1.77

6.55

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

101

481

1.76

6.52

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

101

481

1.76

6.52

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.53

6.47

1.0

1.1

96.00

97.23

titre

0.02

(3019150) Specific gravity of Urine by Refractometry

1380

13123

0.86

6.44

3.3

3.2

1.96

1.14

kg/l

0.41

1079

8337

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

115

2.61

6.43

1.4

1.5

18.96

14.64

pmol/l

0.59

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

150

796

1.58

6.42

1.5

1.3

118.88

189.66

pmol/l

12.49

150

796

(40765096) Chromosome analysis panel by Banding

203

2.18

6.40

1.3

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

255

1512

1.42

6.36

5.3

4.4

24.86

24.68

mmol/l

0.32

246

1455

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.86

6.33

1.1

19.09

22.90

u/l

0.44

(3044009) aPTT.lupus sensitive (LA screen)

5.36

6.31

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.71

6.30

4.4

6.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

10.01

6.28

5.8

8.4

0.23

0.14

mmol/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

147

2.39

6.24

1.1

22.88

11.79

u/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

371

2345

1.33

6.23

3.2

4.0

1768.88

1838.14

u/ml

0.01

328

2047

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.23

6.20

1.0

1.1

319.40

278.14

u/ml

—

(37208534) Antinuclear antibody arbitrary concentration in serum

180

2.23

6.11

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

220

1283

1.44

6.03

1.1

0.66

0.99

u/ml

0.65

101

652

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

426

1.77

5.97

1.0

805.10

678.60

ng/l

1.71

296

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

428

1.76

5.88

1.0

47.26

44.30

ng/l

0.27

305

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.56

5.82

3.1

14.9

104.25

101.33

g/l

0.37

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

309

1.89

5.81

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

382

1.79

5.75

2.5

1.8

2.17

2.19

u/field

0.01

192

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

425

1.75

5.74

1.0

330.90

375.46

ng/l

0.67

309

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

388

0.28

5.74

1.4

1.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.15

5.72

1.5

1.2

5.45

6.40

mmol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

172

968

1.49

5.69

1.4

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

207

1209

1.43

5.66

1.7

1.6

35.63

14.44

e6/l

0.82

149

871

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.04

5.66

1.4

1.2

—

(3025577) Chromium [Mass/volume] in Blood

355

1.81

5.60

2.1

2.2

2.40

2.46

ug/l

0.05

307

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

150

2.28

5.56

1.6

1.5

12.07

8.64

ug/l

2.52

150

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.05

5.44

3.9

3.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

163

2.20

5.38

1.1

1.3

1.30

9.72

u/ml

0.97

150

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.00

5.31

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.49

5.25

1.3

1.2

0.48

0.64

mmol/l

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.90

5.24

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

118

2.40

5.20

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2922

22560

1.11

5.18

3.8

4.1

21.77

21.13

1.45

1366

11067

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

341

1.79

5.12

1.4

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

207

1233

1.41

5.12

1.8

1.6

3595.45

1153.23

e6/l

0.38

169

942

(3026470) Cobalt [Mass/volume] in Blood

372

1.75

5.10

2.3

2.2

4.34

3.18

ug/l

0.71

352

(3012494) Peanut IgE Ab [Units/volume] in Serum

206

2.03

5.09

1.2

6.19

17.80

u/ml

0.44

151

(3045683) HLA typing for celiac disease panel - Blood or Tissue

330

1.80

5.07

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

319

1.81

5.01

1.5

1.2

—

(3020650) Glucose [Presence] in Urine

218

0.23

4.95

1.3

1.4

0.50

0.00

estimate

—

218

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

195

1164

1.40

4.79

1.1

16.19

15.16

au/ml

0.07

319

(3009871) Measles virus Ab [Titer] in Serum

252

1.89

4.78

1.6

1.7

2760.00

2941.67

titre

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

399

0.35

4.78

1.1

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

349

1.75

4.77

1.4

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

539

0.45

4.71

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

11.11

4.54

1.3

1.7

2.09

2.38

mmol/24h

—

(3043410) Blood group antigens tested for on Red Blood Cells

126

2.25

4.54

1.3

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

287

1.80

4.53

1.2

1.1

1295.90

258.14

ng/l

0.57

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

170

2.06

4.52

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.11

4.45

2.8

3.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

408

0.39

4.42

1.1

1.6

—

(3005033) Fetal Nuchal fold Thickness US

395

0.38

4.40

1.1

1.5

1.32

1.29

—

284

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.33

4.39

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

132

746

1.48

4.38

3.2

3.6

7.92

4.88

nmol/l

0.76

127

729

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

103

555

1.55

4.28

1.1

8.90

9.53

iu/ml

0.07

136

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

152

2.09

4.24

1.8

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2729

24339

0.91

4.23

3.8

3.0

2.27

0.30

estimate

0.76

393

4934

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

296

1.75

4.12

1.1

1.77

1.18

u/l

0.41

145

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

161

2.02

4.02

2.9

3.4

27.04

27.89

umol/l

0.14

131

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

8.33

4.00

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.10

3.95

1.2

1.1

—

0.45

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

380

2566

1.24

3.93

1.3

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

192

0.26

3.93

1.0

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

180

1.95

3.92

1.4

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

123

703

1.46

3.90

1.3

0.17

0.29

nmol/l

3.56

485

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

124

2.15

3.89

1.1

591.67

950.00

titre

1.12

(3028717) Thiamine [Mass/volume] in Blood

3.33

3.86

1.0

69.43

69.69

ug/l

0.01

(3003694) ABO and Rh group [Type] in Blood

2373

18364

1.10

3.85

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

176

1971

0.74

3.82

2.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

9.72

3.81

1.0

1.3

27.88

59.00

umol/24h

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

524

1.53

3.81

2.3

1.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.83

3.78

11.5

8.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.83

3.78

1.3

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.76

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

4.01

3.75

1.1

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.01

3.75

1.2

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

467

0.48

3.69

1.1

1.5

1.06

1.13

ratio

0.21

287

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.58

3.63

1.0

1.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.87

3.63

7.5

6.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

169

1037

1.36

3.62

1.1

5.61

6.30

u/ml

0.16

487

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

598

4259

1.18

3.60

1.9

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.64

3.58

1.7

79.45

29.87

pmol/l

1.01

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.74

3.51

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

467

0.50

3.46

1.1

1.5

0.91

0.95

ratio

0.28

287

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

467

0.50

3.46

1.1

1.5

1.32

1.21

ratio

0.15

288

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

5.36

3.43

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

5.36

3.43

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

3.07

3.42

1.1

1.3

1.58

1.29

1.71

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.63

3.38

3.1

2.9

13.74

3.99

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

463

0.50

3.38

1.1

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

468

3283

1.20

3.37

1.6

1.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.17

3.36

1.1

1.8

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

6.06

3.36

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

527

1.49

3.34

1.3

1.8

5.99

3.33

mg/l

3.19

510

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

502

0.53

3.29

1.2

1.5

47.72

62.93

ug/l

1.97

412

(3005532) Lymphocytes/Leukocytes in Pleural fluid

100

2.17

3.26

1.5

1.3

70.31

60.13

0.93

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.70

3.26

3.4

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

355

0.44

3.25

1.5

1.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

268

1.68

3.21

1.4

1.2

—

(3008898) HLA-B27 [Presence]

288

1935

1.25

3.19

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

101

2.15

3.19

1.9

3.6

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.62

3.19

1.0

1.1

0.08

0.20

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

112

658

1.42

3.15

1.5

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

196

1258

1.30

3.15

1.1

0.97

2.12

u/ml

2.49

112

673

(3023511) Choriogonadotropin [Units/volume] in Urine

308

1.63

3.15

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

542

3876

1.17

3.14

1.9

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

226

1.74

3.13

2.0

9.75

9.98

mg/l

0.12

191

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

732

5359

1.15

3.11

3.7

2.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

154

1.90

3.09

1.3

1.5

14.45

14.75

u/ml

0.01

117

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.44

3.09

1.0

1.1

0.21

0.90

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

170

1075

1.32

3.05

1.1

4.31

4.75

u/ml

0.12

565

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.30

3.04

1.6

1.7

15.00

19.20

nmol/l

—

(3026726) Creatinine [Moles/volume] in Specimen

2.85

3.04

2.3

1.6

477.07

203.73

umol/l

0.41

(44813793) Dust mix specific IgE antibody measurement

390

1.54

3.03

1.2

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

231

1.70

2.93

1.0

19.19

19.72

mmol/l

0.42

225

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

146

1605

0.75

2.88

2.1

2.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

7.14

2.88

1.3

1.0

2190.00

2532.86

titre

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.38

2.81

1.1

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

392

2756

1.19

2.81

1.1

157.08

228.63

titre

0.26

(3000012) Reticulocyte production index

577

1.42

2.77

1.7

2.3

0.89

0.86

0.16

363

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.13

2.74

1.2

2.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

223

1.68

2.74

1.0

7.85

7.08

kpa

1.62

190

(3006598) pH of Arterial cord blood

223

1.68

2.74

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

223

1.68

2.74

1.0

-0.01

-1.82

mmol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

198

1.73

2.74

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

150

949

1.32

2.72

1.1

0.39

0.45

u/ml

0.08

345

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

6.25

2.67

3.5

4.8

13.53

17.39

mmol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

111

673

1.38

2.66

1.3

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.23

2.59

1.1

0.07

0.91

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.23

2.59

1.1

0.07

2.49

u/ml

0.92

(3021706) Oxygen [Partial pressure] in Arterial cord blood

221

1.66

2.57

1.0

3.01

3.39

kpa

1.14

189

(40758358) Immune stain study

2.94

2.57

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

152

0.33

2.56

7.3

5.6

8.17

7.99

—

152

(40761995) Spermatozoa Progressive [#/volume] in Semen

153

0.33

2.55

3.7

2.8

47.83

43.66

—

153

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

718

0.66

2.54

1.4

1.5

—

13.74

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

100

2.00

2.52

1.6

1.5

194.57

138.87

titre

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

5.55

2.49

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

107

1.95

2.45

1.0

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

284

1.56

2.41

1.0

11.27

8.48

mu/l

1.29

252

(3001729) Color of Synovial fluid

2.48

2.40

1.1

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.70

2.34

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.17

2.34

1.1

1.0

1.48

0.03

u/ml

1.05

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.63

2.30

1.1

2.27

1.50

umol/24h

0.74

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

153

1.74

2.26

1.3

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.32

2.24

3.3

2.4

—

(40758292) HTLV I+II Ab panel - Serum

141

1.77

2.24

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.95

2.23

2.6

3.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.03

2.22

1.5

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.87

2.17

1.3

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.87

2.17

19.1

6.8

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

292

1.51

2.17

1.2

1.3

0.50

0.57

ratio

2.03

162

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.50

2.10

1.3

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.98

2.09

2.0

2.2

—

(4038314) Semen analysis, post vasectomy

2.62

2.09

1.1

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.21

2.06

4.0

4.8

421.60

359.50

umol/l

—

(3016135) IgD [Mass/volume] in Serum

4.17

2.05

1.2

1.3

258.15

50.93

mg/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.36

2.03

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.89

2.02

1.3

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

135

1.73

1.96

1.2

1.3

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

2.78

1.92

3.0

3.5

20.43

22.57

umol/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.78

1.92

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

2180

17258

1.07

1.90

3.4

3.3

0.01

0.00

estimate

0.58

575

5686

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

107

1.79

1.82

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

107

1.79

1.82

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

107

1.79

1.82

1.4

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

315

0.58

1.79

1.3

1.2

9.41

10.06

mm/h

0.14

315

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

2.02

1.78

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.17

1.77

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.78

1.76

1.1

1.3

—

192.17

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

202

1405

1.20

1.76

1.4

1.3

169.82

215.08

miu/ml

0.89

701

(3001019) Free T4 and TSH panel - Serum or Plasma

343

3263

0.87

1.74

1.8

1.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

166

1.61

1.74

1.5

2.1

28.22

39.78

u/l

0.38

153

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.67

1.68

1.0

1.1

7.24

1.03

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

110

1.74

1.68

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

201

1.54

1.67

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

262

1.46

1.67

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

262

1.46

1.67

1.7

1.8

2.92

3.49

u/field

0.12

178

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.96

1.66

1.2

2.1

3.63

4.26

ug/l

0.40

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

136

1.66

1.65

1.2

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

130

1.67

1.64

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

130

1.67

1.64

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

130

1.67

1.64

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

130

1.67

1.64

1.1

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

118

1.70

1.61

2.3

2.0

0.14

0.16

nmol/l

0.14

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.56

1.61

1.0

1.1

—

34.82

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.47

1.54

1.0

0.05

0.03

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

314

2295

1.14

1.52

1.5

1.4

25.43

34.56

iu/l

5.38

254

1932

(3017509) Phencyclidine [Presence] in Urine

2.50

1.50

1.8

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

2.50

1.50

1.0

1.2

435.78

106.32

u/l

—

(3047181) Lactate [Moles/volume] in Blood

593

1.28

1.48

4.8

2.2

1.53

1.27

mmol/l

1.25

499

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

256

1.43

1.47

1.2

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

213

0.55

1.46

1.1

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.78

1.43

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.74

1.41

3.8

3.2

—

(4212803) Bone marrow aspirate examination

2.04

1.40

1.2

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.63

1.35

1.0

0.05

7.42

u/ml

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.80

1.34

3.0

1.9

4.92

4.98

kpa

0.07

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.80

1.34

3.0

1.9

10.18

10.63

kpa

0.26

(3041672) Baker's yeast Ab [Presence] in Serum

2.14

1.30

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

277

1.38

1.30

1.1

1375.52

1515.88

miu/ml

0.40

277

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.08

1.28

1.2

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.15

1.19

1.3

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.17

0.0

1.1

—

74.93

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.03

1.17

1.1

—

23.07

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.91

1.10

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

236

2214

0.89

1.08

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.67

1.07

1.3

1.2

0.34

1.33

u/ml

0.47

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

224

1.38

1.06

3.0

3.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.87

1.00

1.1

1.0

—

(3013762) Body weight Measured

0.00

0.98

0.0

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

172

1.41

0.95

3.2

3.3

68.01

126.74

umol/l

1.57

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.74

0.92

1.1

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.72

0.91

1.3

2.5

—

(3009677) Dengue virus Ab [Presence] in Serum

2.08

0.89

1.0

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.08

0.89

1.2

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

109

0.53

0.88

1.7

2.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

553

1.21

0.87

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

403

0.76

0.87

5.2

8.2

29.59

150.99

ug/l

1.03

271

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

233

1.32

0.86

4.2

2.9

0.78

1.22

1.11

233

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.73

0.85

1.0

1.1

1.53

1.06

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

309

1.27

0.82

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

233

0.71

0.75

1.7

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.08

0.74

1.2

1.4

149.60

368.30

nmol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.48

0.74

1.3

1.7

—

(3025130) Human papilloma virus identified in Specimen

792

0.85

0.74

1.7

1.8

—

(4281824) Cell count and differential, peritoneal fluid

104

751

1.15

0.72

1.4

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

594

0.84

0.65

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.59

0.62

1.7

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.61

0.58

1.0

1.1

5.03

9.55

u/ml

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.72

0.58

1.2

1.0

8.83

22.66

u/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

169

1288

1.09

0.53

1.2

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

199

0.75

0.53

1.2

41.21

66.02

u/ml

1.32

194

(3002523) Influenza virus A Ag [Presence] in Specimen

169

1289

1.09

0.53

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

552

0.86

0.51

4.0

6.6

46.84

104.45

u/ml

1.29

210

(3034092) Cytoplasmic Ig cells/cells in Blood

1.51

0.51

3.1

4.3

0.23

0.19

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

307

1.19

0.51

1.6

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

783

6769

0.96

0.51

1.6

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

568

0.86

0.50

1.2

20.00

20.48

u/ml

0.04

211

(46236302) HLA-C [Type] by High resolution typing

1.58

0.49

1.0

—

(40763590) HLA-DQ beta [Type]

1.58

0.49

1.0

—

(40768795) Lymph node Pathology biopsy report

102

763

1.11

0.48

1.2

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.49

0.48

1.5

2.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

309

0.83

0.41

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.41

0.0

1.2

—

270.13

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.36

0.41

4.9

3.5

—

0.00

estimate

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

393

3126

1.05

0.40

3.4

4.4

35.62

54.17

u/ml

2.56

375

3042

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.37

0.40

1.3

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

521

1.12

0.38

1.2

1.3

5.18

3.00

u/ml

0.34

196

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

350

0.86

0.38

1.6

2.8

40.66

38.04

0.25

137

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

141

1.24

0.37

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.39

0.36

1.9

1.0

1.17

mmol/l

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.39

0.35

1.5

1.3

1.23

1.97

mg/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

1.16

0.34

1.4

1.3

—

(40760410) HLA-B [Type] by High resolution

1.35

0.34

1.0

—

(40760409) HLA-A [Type] by High resolution

1.35

0.34

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.35

0.34

1.0

1.1

6.00

6.02

mmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.35

0.34

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.66

0.33

1.3

1.1

—

(3013862) HLA-DP [Type]

1.28

0.32

1.0

—

(4133840) Spirometry

201

0.83

0.31

1.5

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.69

0.31

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.34

0.30

1.1

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.27

0.30

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

576

0.91

0.28

1.4

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.30

0.26

1.8

3.2

52.50

26.35

mg/l

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.30

0.26

1.6

1.7

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.9

—

421.80

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.20

0.0

1.0

—

1.19

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

152

1.15

0.20

1.7

2.7

96.06

161.10

ng/l

—

(3022475) Manganese [Moles/volume] in Blood

1.16

0.19

1.0

1.4

0.16

0.15

umol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1732

14576

0.99

0.18

3.5

3.1

0.07

0.19

0.80

131

(3014599) Egg white IgE Ab [Units/volume] in Serum

515

1.07

0.18

1.3

36.11

5.33

u/ml

0.49

169

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.17

0.18

3.9

2.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.17

0.18

1.3

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.14

0.17

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

180

0.88

0.17

1.2

1.1

24.53

43.26

iu/ml

1.18

180

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.12

0.17

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.73

0.17

1.2

—

(3012501) Base excess in Blood by calculation

679

1.06

0.17

8.8

2.6

3.02

2.34

mmol/l

1.56

459

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.17

0.16

2.6

1.9

1.00

0.54

u/field

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.15

0.15

1.3

1.5

0.44

0.50

e9/l

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.81

0.14

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

469

0.94

0.14

1.2

1.1

1.23

2.41

u/ml

0.38

143

(3003329) Lymphocytes/Leukocytes in Synovial fluid

528

0.95

0.13

1.8

1.5

28.70

36.11

0.83

307

(40765089) Chromosome analysis panel - Blood by G-banded

159

1.10

0.11

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

354

0.94

0.11

1.1

—

(40768793) Breast Pathology biopsy report

193

1641

0.98

0.09

1.4

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.80

0.08

2.4

3.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

239

0.94

0.08

1.6

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.09

0.07

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.07

0.07

1.1

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

119

972

1.02

0.06

3.4

3.1

1.54

1.19

mmol/l

2.74

114

961

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

270

0.96

0.05

2.1

1.9

2.54

3.72

u/ml

0.27

(44806420) Estimation of glomerular filtration rate

592

0.98

0.02

2.3

2.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

244

1.02

0.01

2.0

29.00

31.24

0.41

244

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

152

0.99

0.00

2.6

10.94

430.74

pmol/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

289

1.01

0.00

1.4

1.7

5.70

7.93

ug/l

0.31

205

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

697

1.00

0.00

4.8

4.3

27.93

69.83

u/ml

2.61

690

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

4.3

—

1.16

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.94

-0.00

1.6

2.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

268.38

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

46.83

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.4

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.7

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.93

-0.00

1.0

1.1

0.46

2.41

u/ml

—

Mortality – FinRegistry

↥

Association

Association between endpoint CPAP and mortality.

Females

Parameter	HR [95% CI]	p-value
CPAP	3.242 [2.82, 3.73]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.398

During the follow-up period (1.1.1998 — 31.12.2019), 3807 out of 20443 females with CPAP died.

Males

Parameter	HR [95% CI]	p-value
CPAP	2.609 [2.26, 3.01]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 5627 out of 33117 males with CPAP died.

Mortality risk

Mortality risk for people of age

years, who have CPAP.

N-year risk	Females	Males
1	0.307%	0.48%
5	2.055%	2.949%
10	4.78%	7.29%
15	9.292%	13.455%
20	15.925%	22.439%

Relationships between endpoints

↥

Index endpoint: CPAP – Continuous positive airway pressure

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Continuous positive airway pressure

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints